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ABSTRACT 
Background: Polymyositis (PM) and dermatomyositis (DM) are rare idiopathic 
inflammatory myopathies. Common clinical features are proximal muscle weakness and 
reduced muscle endurance, which can lead to activity limitation and reduced health-
related quality of life (HRQoL). The current body of knowledge about hand function, 
activity limitation, and HRQoL in patients with PM and DM is limited. 
Aim: The overall aim of this thesis was to describe and explore hand function, activity 
limitation, work ability, and HRQoL in patients with PM and DM. 
Method: Four papers with cross-sectional, over-time, or intervention pilot study designs 
have been applied in this thesis. Descriptive, comparable, over time, and correlational 
statistics have been used. In all, 143 patients with PM and DM participated in the studies. 
Results: The results in this thesis showed that both women and men with PM and DM 
have reduced grip force and HRQoL compared to gender- and age-matched values from 
the literature. The reduced grip force and HRQoL were measured at the time of diagnosis 
in both women and men. Women had a reduced grip force at years 1-4 and at 6 years 
after diagnosis, while the men were affected up to 2 years after diagnosis. The HRQoL 
was rated lower than the normative values up to 6 years after diagnosis in women and 2 
years following diagnosis in men. The grip force had a moderate to high correlation to the 
HRQoL dimensions of Role Physical, General Health, Vitality, and Mental Health. A hand 
exercise intervention seemed to be feasible to perform with good adherence but 
generated few individual improvements in hand function and activity performance why the 
protocol needs to be adjusted. Patients with reduced hand grip strength also 
demonstrated activity limitation (according to the Disability of the Arm, Shoulder, and 
Hand questionnaire) and reduced dexterity. In patients with PM and DM, 44% worked full-
time (40 h/week), 31% worked part-time, and 25% were on full-time sick leave. More than 
50% of patients with PM and DM self-rated their work ability as “poor” or “less good”. 
Physically strenuous work components were present “quite often” to “very often” in up to 
79% of the patients and were more prevalent in patients on sick leave ≥2 years. For 
those working, interfering factors in the work environment concerned task and time 
demands. Supporting factors were the meaning of their work, interactions with co-
workers, and others. A low self-rated work ability was correlated moderate-high with a low 
percentage of full-time employment, the presence of work-related risk factors, and 
constraints in the work environment.  
Conclusion: Patients with PM and DM have reduced hand grip strength, lower ratings on 
HRQoL, and poor to less good self-rated work ability and the low grip strength may 
influence HRQoL whereas the proximal weakness seems to affect the ability to work. 
Measures of hand function and work ability should be included in care of patients with PM 
and DM to guide interventions that could minimize impairment and as measures in the 
evaluation of treatment. 
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SAMMANFATTNING 
Bakgrund: Polymyosit (PM) och dermatomyosit (DM) är ovanliga inflammatoriska 
sjukdomar. Vanliga symtom vid PM och DM är nedsatt muskelstyrka och uthållighet i de 
proximala musklerna, dvs. de som ligger nära bålen. Den nedsatta muskelfunktionen 
påverkar de dagliga aktiviteterna och livskvaliteten. Kunskapen är begränsad om hur 
handfunktion, aktivitetsförmåga och livskvalitet är påverkad hos personer med PM och 
DM. 
Syfte: Målet med denna avhandling var att undersöka handfunktionen, 
aktivitetsförmågan, arbetsförmågan och livskvaliteten hos personer med PM och DM. 
Metod: Avhandlingen innehåller fyra delarbeten med sammanlagt 143 patienter med PM 
och DM. Tvärsnitt, över tid- och intervention pilot design har använts i denna avhandling. 
Vid dataanalys har beskrivande-, jämförande-, över tid- och sambandsstatistik använts. 
Resultat: Resultatet i avhandlingen påvisar att både kvinnor och män med PM och DM 
har nedsatt gripkraft och livskvalitet. Både hos kvinnor och män var gripkraften och 
livskvaliteten nedsatt vid sjukdomsdebut. Hos kvinnorna var gripkraften och livskvaliteten 
även nedsatt upp till 6 år efter sjukdomsdebut medan hos männen upp till 2 år efter 
sjukdomsdebut.  
Handträningsintervention tycks vara möjlig att genomföra med god följsamhet men endast 
få individuella förbättringar i handfunktion och aktivitetsförmåga kunde ses, varför 
träningsprogrammet behöver justeras. 
Av patienter med PM och DM i arbetsför ålder arbetade 44 % heltid (40 timmar/vecka),  
31 % arbetade deltid och 25 % var heltidssjukskrivna. Mer än hälften självskattade sin 
arbetsförmåga som mycket låg eller låg.  
Fysiskt ansträngande moment i arbetet (arbetsrelaterade riskfaktorer) förekom ganska till 
mycket ofta hos upp till 79% och oftare hos de patienter som hade varit sjukskrivna mer 
än 2 år. För de som arbetade ansågs tidskrav och arbetsuppgiftens krav vara ett hinder 
för att bevara arbetsförmågan. I arbetsmiljön ansågs arbetets värde och betydelse, 
interaktion med arbetskamrater och andra som ett stöd för att bevara arbetsförmågan. 
Den självskattade arbetsförmågan hade måttliga till höga samband till arbetsgrad 
(procent i arbete), arbetsrelaterade riskfaktorer samt hinder och möjligheter i arbetsmiljön. 
Konklusion: Patienter med PM och DM har nedsatt gripkraft, livskvalitet och 
arbetsförmåga. De symtom som är sjukdomsspecifika tycks påverka förmågan att 
fortsätta arbeta. Det finns ett behov av att undersöka handfunktion och arbetsförmåga 
hos personer med PM och DM i vården för att minimera funktionsnedsättning och för att 
utvärdera behandling. 
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1 Background 
The background will describe and explore hand function, activity limitation, work ability, 
and health-related quality of life (HRQoL) in patients with polymyositis (PM) and 
dermatomyositis (DM) using the framework of the International Classification of 
Functioning, Disability, and Health (ICF) (1). 
1.1 Polymyositis and dermatomyositis 
Polymyositis and DM are idiopathic, chronic inflammatory diseases leading to muscle 
weakness and low muscle endurance that result in restrictions in activity performance and 
a low HRQoL (2-4). Polymyositis and DM are rare diseases with an annual incidence of 
between approximately 6-8 cases per 100,000 person-years and an annual prevalence of 
14-17 persons per 100,000 (5). Data from Sweden in 1993 show approximately the same 
prevalence: between 3.3-7.4 cases per 100,000 (6). These disorders often affect persons 
who are still of a working age, as the majority of the patients are 45-64 years old at 
disease onset (5). There are approximately twice as many women than men with PM and 
DM (5). 
The disease course varies from a severe, progressive systemic disease with multi-organ 
involvement to a slowly progressive onset mainly affecting muscle performance (7). The 
prognosis varies, and the overall improvement of muscle performance is slow, taking 
place over a period of months. Approximately 20% of the patients go into remission and 
recover muscle strength, whereas the majority of the patients develop persisting muscle 
weakness and low muscle endurance that has a negative effect on muscle and activity 
performance (2, 3). 
1.1.1 Definition and diagnosis 
Polymyositis and DM affect both body function and body structure in the skeletal muscle, 
including the skin and other organs such as the oesophagus, heart, and lungs (7-11). 
These symptoms all contribute to the morbidity and mortality rate (<10%) that exists in 
patients with PM and DM (9, 11). The impairments in patients with PM and DM include 
reduced muscle strength and muscle endurance more commonly existing in the proximal 
muscles (7, 10), which can lead to difficulties in activities, participation and negatively 
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affects HRQoL (2-4). What distinguishes PM from DM is that DM also has rash, most 
commonly on the face, knuckles, and upper eyelids (7). 
Bohan and Peter defined the criteria to diagnose PM and DM in the 1970s (12). In their 
definition, there are five major disease criteria to diagnose PM and DM (12) (Figure 1): 
 
 
 
 
 
 
 
 
 
 
Figure 1. Bohan and Peter’s five major diagnostic criteria (12). 
 
 
Polymyositis and DM can be further classified as definite, probable, or possible disease 
(12). For definite DM, the patient should have three or four of the diagnostic criteria 
(including rash), while for definite PM, the patient needs four criteria (without rash) (12). 
For probable DM, the patient should have three criteria (including rash), while at least 
three criteria (without rash) are required for probable PM (12). For possible DM, two 
criteria are required (including rash), and possible PM requires two criteria (without rash) 
(12). This thesis included patients with definite and probable PM or DM. 
1. Symmetrical proximal muscle weakness 
2. Elevation of serum muscle enzymes, such as creatine kinase (CK) and aldolase 
3. Abnormal electromyographic findings, such as the following: 
 Short, small, polyphasic motor units  
 Fibrillations, positive sharp waves 
 Insertional irritability 
 Bizarre high-frequency repetitive discharges 
4. Abnormal muscle biopsy findings, such as the following: 
 Mononuclear infiltration 
 Regeneration, degeneration 
 Necrosis 
5. Dermatological features of DM, such as Gottron´s sign, papules, or heliotrope rash 
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1.1.2 Treatment 
Treatment in PM and DM is largely pharmacological, and physical therapy is also 
recommended as exercise can be used as intervention (7, 13-18). However, no studies 
have evaluated the effectiveness of different occupational therapy interventions in PM 
and DM. 
Pharmacological treatment of PM and DM is based on high doses of glucocorticoids and 
immunosuppressive drugs, such as methotrexate and azathioprine. These drugs are 
used to minimize the usage of steroids (7, 13-15). A majority of the patients respond to 
the pharmacological treatment, but their effectiveness is inconclusive (7).  
Despite the fact that most patients have a favourable response to pharmacological 
treatment, a majority still develops sustained disability (2, 3). Therefore, the importance of 
endurance exercise in addition to pharmacological treatment is increasingly being 
recognised (16).  
Earlier patients with PM and DM were advised to refrain from exercise and physical 
activity since it was believed that exercise increased the inflammation in myositis (17). 
During the last two decades, several studies have shown that aerobic, resistance, and 
endurance exercise have been well tolerated without signs of increased disease activity 
or inflammation (14, 15, 17, 18). New evidence even suggests that exercise may reduce 
inflammation (17). The exercise interventions performed in PM and DM are intended to 
increase muscle strength in the proximal muscles and to improve aerobic capacity 
(13-15). 
1.2 Theoretical framework 
The ICF are used as the theoretical framework in this thesis for classification of 
functioning, disability, and health. The ICF describes the patients and the measures used 
as well as the results for the following ICF components: body functions, body structures, 
activities, and participation.  
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1.2.1 The International Classification of Functioning, Disability 
and Health (ICF) 
There is a need for a common language regarding health since the World Health 
Organization (WHO) has the task to work for public health (19). The WHO requires 
statistical and epidemiological reports about public health from its members (19, 20). For 
several years, the International Statistical Classification of Disease and Related Health 
Problems (ICD-10, 1994) was used to determine these reports on death or mortality (20). 
However, the ICD-10 did not give a comprehensive picture about public health, and there 
was also a need to report health outcomes that were non-fatal (20). For instance, some 
conditions affect health and limit function in everyday life even though they are not 
considered fatal, e.g. depression (20).  
Health can be described as follows: ‘[...] health is both a matter of how long one lives and 
how well one lives […]’ (20) (p. 566). Therefore, a need developed for a classification 
system with a common language that would enable comparisons between countries and 
health care systems and to establish a common scientific base to understand health and 
the consequences of disease (1, 21). In 2001 the ICF was endorsed by the 54th World 
Health Assembly for international use (19). The ICF is based on an earlier version called 
the International Classification of Impairments, Disabilities, and Handicaps (ICIDH) from 
1980 (20). One of the differences between these versions is that the ICF focus on health 
components, while the ICIDH had concentrated on the consequences of disease (1). The 
ICF provides a new, more neutral stand and highlights functioning as a component of 
health (1, 20). When the ICF was developed, cultural and linguistic aspects were 
considered, which was a limitation of the earlier version (ICIDH) (20). Thus, the ICF 
provides a common language to describe health that is used in research to mediate the 
results amongst different professions in health care and between different countries  
(1, 19). 
The ICF has a base in both a medical model and a social model (1, 19). The medical and 
social model has some contradictory features but should be combined for a 
comprehensive picture of health (1, 19). The medical model sees the disability as a 
problem within the person, which is directly caused by a disease; the health care system 
has the responsibility to cure or treat the disease. Health care systems have a strong 
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influence from the political level, which has the obligation to facilitate good healthcare with 
the mission to cure disease. The social model sees the disability as a socially created 
problem generated by society. The disability is not due to the person but instead to a 
complex combination of circumstances. From this perspective, the society needs to 
change to prevent disability (1, 19).  
The general view of disability needs to consider these models. According to the ICF, both 
models have been combined into the biopsychosocial model, which views health as a 
combination of biological, individual, and social perspectives (1, 19). In addition, health 
care providers have the obligation to involve the patient in the choice of treatment, and 
the patients have the right to autonomy according to the Swedish Health and Medical 
Services Act (22). 
The different components in the ICF interact with each other according to the following 
model (Figure 2): 
 
 
 
 
Figure 2. The ICF model and the interactions between the ICF components (1, 19). 
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In Figure 2, the reverse arrows between the components illustrate that it is not only in the 
person; the disability can be caused by but also that the environment or personal factors 
affect disability (1, 19). The ICF can be used to describe how a person is affected by his 
or her health condition, including the bodily symptoms as well as the possibility for 
participation. Furthermore, the environment’s influence and personal factors can affect a 
person’s ability to handle the health condition (1, 19) 
The different components are defined as follows (1, 19): 
 Body functions are both the physiological and psychological systems in the 
body. 
 Body structures are the anatomical part of the body, such as organs, limbs, and 
their components.  
Disabilities in both body function and body structure are labelled as impairment. 
 
 Activities are the ability to execute a task or an action by an individual, and 
disability in activity performance is labelled as activity limitation. 
 Participation is defined as involvement in a life situation, and disability is defined 
as participation restrictions.  
Activity and participation involve learning and applying knowledge, carrying out 
daily routines, mobility, self-care, domestic life, etc.  
 
 Environmental factors involve the physical, social, and attitudinal environment 
in which people conduct their lives.  
 
 Personal factors include gender, age, coping styles, social background, 
education, overall behaviour pattern, and other factors that influence how 
disability is experienced by the individual. 
The different components in the ICF have a hierarchical order with a one to four digit level 
to describe functioning, disability, and contextual factors, including about 1200 categories 
altogether that are used to describe patients with different health conditions. The 
categories in the activity and participation components can be single tasks or multiple, 
complex compositions of tasks evaluated as either being able to do a task or not but also 
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if someone is doing the task or not (1). For the level-one classification (chapters), the 
categories are generally described and are gradually more specific onwards to the level-
four classifications. In this thesis, a one-level classification will be applied.  
To facilitate clinical application, comprehensive core sets have been developed for 
different diagnoses (23-25).  
1.2.1.1 ICF and chronic conditions 
During 2002-2003, both brief and comprehensive core sets were developed for 12 
different chronic conditions, including rheumatoid arthritis (RA) and osteoarthritis (23) but 
not yet for myositis. The purpose of the brief core set was to facilitate a minimum of 
categories that should be applied in clinical practice and research when assessing health 
in the different conditions. The comprehensive core set aims to describe a broader picture 
of health from a multidisciplinary perspective (23). The development of these ICF core 
sets included a method using a formal decision-making and consensus process, a Delphi 
exercise, and a systematic review alongside with empirical data collection (23).  
In the ICF comprehensive core set for RA, there are 96 categories; the brief version has 
39 categories, and both versions include the components of body function and structure, 
activity and participation, and environmental factors (26). For the ICF core set in RA, 
studies have been done to validate it to different health care providers (27-29) and to the 
patient perspective (30, 31). These studies indicate that there are several categories in 
the ICF core set for RA that are included based on the perspective of both the health 
professionals and the patient but that there are also areas not included in the ICF core set 
(27-31). In an article using focus groups to describe the experience of systemic sclerosis, 
86 categories were identified and linked to the ICF components of body function, body 
structure, activities, participation, environmental and personal factors, as well as the 
health condition itself (32).  
For myositis, at present there is no developed ICF core set. In a review article about the 
disabling nature of idiopathic inflammatory myopathies, links to the ICF were discussed, 
and it was suggested that all the components in the ICF were represented when 
describing myositis (33). 
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Even though there is no ICF connected core set, the International Myositis Assessment 
and Clinical Studies (IMACS) group has established a core set of measures to use to 
evaluate disease activity in myositis (34). The six-item core set includes assessments 
evaluated by the physician, patient-reported measures, and laboratory measures (34) 
(Table 1). 
 
 
Table 1. Measures included in the IMACS six-item core set (34). 
 Measure 
By the physician Physician Global Assessment of disease activity (PGA) rated on a Visual 
Analogue Scale (VAS) 
 Muscle Strength (Manual Muscle Test in eight muscle groups (MMT-8) 
 Extra muscular activity (VAS) 
By the patients Patient’s global assessment of health (VAS) 
 Physical Functioning (Health Assessment Questionnaire, HAQ) 
Laboratory measures Creatine Kinase (CK) 
 
 
The IMACS group has also developed a consensus on outcome measures and 
improvement of disease activity (34). A minimum of 15% improvement in muscle 
strength and physical function is considered clinically meaningful for patients with PM 
and DM (34). Another organisation working to establish patient-reported outcomes in 
rheumatic diseases is the Outcome Measures in Rheumatology (OMERACT). The 
OMERACT currently has a myositis special interest group that aims to establish patient-
reported outcomes in myositis (35). Whether these will be connected to the ICF is not 
known. 
The main areas of this thesis include hand function, activities, work ability, and HRQoL.  
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1.3 Hand function 
In general, hand function is important in many activities and includes the ability to move 
the hands and fingers and having the strength and endurance to perform daily activities 
for prolonged periods (36).  
Mobility, strength, and the absence of pain are required to use the hands in the most 
effective way (37). Polymyositis and DM mainly affect the proximal muscles; however, 
some previous researchers have reported that the distal muscles may also be involved (7, 
38, 39). One study referred to patients in the late phases of PM and DM (39), and 
another was conducted in patients with cancer-associated dermatomyositis (CAD) (38).  
There are also indications that arthritis in the wrist and finger joints 
(metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints) is more common 
in patients with inflammatory myopathies than was previously thought (≈20%) (40). 
Arthritis in the hands is known to lead to deformities, dysfunction, and reduced range of 
motion (41, 42). However, in the studies included in this thesis, PM and DM patients with 
arthritis or other comorbid diseases that could affect the hand were excluded. Measures 
of mobility and strength of the hand are linked to the ICF component of body function, 
while dexterity is linked to activities and participation (43-46). In this thesis, the power of 
hand grip will be assessed by two different measures. The Grippit©, which measures grip 
force, will be used in Papers I and II (in Newton, N) (47). In Paper III, a computer-
connected Jamar dynamometry will be used, which measures grip strength (in kilograms, 
kg) (48). The Grippit© assesses grip force by calculating the average force used when the 
patient squeezes as hard as he or she can for 10 seconds (47). The measure of grip force 
indicates the endurance to maintain the power of the grip. This differs from the measure 
of hand grip strength (Jamar) where the patients are asked to squeeze as hard as they 
can (peak strength) three times, and the average of these three trials is taken as the 
measure (47, 48). Since these two assessments measure different entities, they are not 
comparable (48).  
1.3.1 Hand exercise 
Hand exercise interventions are commonly used as a treatment to improve hand function 
and to improve or maintain activity performance (49). In rheumatic or muscle-affecting 
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diseases, studies on hand exercises have indicated improvement in hand function (50-
54). These hand exercise studies usually include movements to enhance range of motion 
(ROM) and/or hand strength (51, 55, 56). An effective prescription (number of repetitions 
and frequency) for hand exercises to improve hand function has not been established 
(41). In general, to enhance strength and endurance, the American College of Sports 
Medicine (ACSM) recommends exercise 2–3 days per week, with every movement 
repeated 8–12 times (57). To enhance muscle strength and endurance over the exercise 
period, resistance, frequency, or duration must be increased (the progressive overload 
principle) (57). Hand exercises included in an occupational therapy programme showed 
increased activity performance in patients with RA (58). Until recently, no studies had 
evaluated the feasibility and the effectiveness of a hand exercise intervention in patients 
with PM and DM. 
1.4 Activities 
The disability that the myositis causes increases significantly during the disease course 
(3, 59), and a substantial number of patients experienced reduced ability to function in 
their environment and manage their activities (2, 4, 60). Thus, patients with PM and DM 
are affected in their activity performance due to the muscle weakness and reduced 
muscle endurance in the proximal muscles. Commonly reported difficulties include rising 
from a chair, walking up stairs, lifting objects, or combing their hair (2, 33, 39). In 
occupational therapy, activity and occupation are two central concepts. 
1.4.1 The concepts of activity and occupation 
There are several different views about what defines activities and occupations in the 
occupational therapy and occupational science literature (61-66). One elementary way to 
differentiate activity from occupation is that occupation has to have a goal and to be 
meaningful (61, 63, 64). 
Nelson (61) describes occupation as two things, occupational form and occupational 
performance (61). Occupational form is the objective environment and sociocultural reality 
where the actual doing/activity performance take place (61). Nelson sees the 
occupational form as the task; when meaning, structure, and a goal are added, 
occupational performance is accomplished (61). Other authors and researchers share this 
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view. Pierce (62) describes occupation as a subjective event that has a form, a pace, a 
beginning, and an end. In contrast, activity is a generalizable classification of human 
actions that is defined by one’s culture (62). In Pierce’s point of view, occupation is 
something that has happened and is dependent on the individual, the place, and the time, 
and can therefore not be repeated (62). An activity becomes an occupation when an 
individual has performed it (62). Turner et al. (63) defines occupation according to four 
statements. Occupation is the doing in a person’s everyday life; it is driven by the 
person’s needs, aspiration, and environment. It relates to the individual’s definition of 
purposeful use of time; occupations are the means a person uses to create balance and 
control in life (63). According to Turner et al. (63), activities are the blocks that together 
create occupation (63). Occupations are based upon a person’s style and are influenced 
and dependent upon that person’s roles (64).  
The concept of activity as described in the ICF has similarities to the description of activity 
made by Golledge (64) and Turner et al. (63), where activities are seen as the bricks that 
together with doing, meaning, need, balance, control, and goals, become an occupation 
(63, 64). According to Pierce, occupation cannot be objective and generalizable because 
it is dependent on the person, the setting, and the time in which it is performed (62) and 
therefore not what the ICF measures in the component activities. In the definition of 
occupational form by Nelson (61), there are some similarities to the ICF’s environmental 
factors and personal factors. Nelson reflects about the values, norms, and roles that the 
ICF includes (61). Based on this discussion between occupation and activities, the 
component activities defined by the ICF are more closely connected to the concept of 
activity, and this concept will be explored in this thesis. One important aspect of activity 
both for the society and the individual is the ability to work (67). 
1.4.2 Work ability 
Work in general is important both for the society and the individual since work has positive 
effects on health and the economy (67). Periods of sick leave should be minimized 
because long-term sick leave affects the individual negatively and may result in reduced 
self-esteem and self-confidence, which makes a return to work more difficult (67, 68). 
Work ability has been described as the relationship between the individual’s resources 
and job demands. These demands include what type of work it is, what the work 
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incorporates, the organization, and the work environment (67, 69, 70). Thus, reduced 
work ability is associated with more physically demanding jobs and older age (69, 71). If 
the demands from work are higher than the individual’s resources, the work ability is 
decreased and needs to be restored, improved, or supported (67).  
Sandqvist and Henriksson (72) suggest a conceptual framework that is of importance for 
the assessment of work functioning (72). They divide work functioning into three 
dimensions: work participation and society (Work Participation), which includes both the 
individual’s ability/opportunity to acquire/maintain a work position in the society and to fulfil 
a work role as well as conditions on the labour market. The second dimension, work 
performance and the individual (Work Performance), involves the individual’s ability to 
satisfactory perform different work tasks necessary for a certain work position. The third 
dimension, individual capacity and physiological/psychological functioning (Individual 
Capacity), involves the physical and psychological attributes of an individual that enable 
work activities, such as muscle strength (72). Work Participation is linked to the ICF 
component participation, Work Performance to the ICF component activities, and the 
Individual Capacity to the ICF component of body functions and structures (72). 
For patients with other rheumatic diseases, such as RA or systemic sclerosis, work ability 
is affected (73, 74). In one previous study conducted in Hungary, 42% of patients with PM 
and DM were not able to work at any time from the onset of the disease due to functional 
impairments and activity limitations caused by the myositis (4). However, limited 
information is available on whether PM and DM affect work ability or confer a risk factor 
for sick leave and early retirement, and the risk factors that affect the work ability have not 
been identified. The symptoms PM and DM may cause might give rise to psychological 
consequences that negatively affect quality of life (3, 4, 75). 
1.5 Health-related quality of life 
According to the WHO, health is a fundamental right of every human and is defined as a 
state of complete physical, mental, and social wellbeing and not merely the absence 
of disease or infirmity (76). The latter (health=absence of disease) definition is more of a 
bio-statistical theory of describing health and defining disease as an organ failure leading 
to disease or ill health. The use of a holistic theory also includes “feeling” and a 
phenomenon of “ability or disability” when describing health (77). There could be disease 
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without affecting feelings, for instance, in a person who is in a coma (77). Since the goals 
of medicine are to save lives and improve quality of life, health is essential in public health 
care (77). 
Several studies have shown that patients with PM and DM rate lower HRQoL compared 
to the general population (3, 4, 75). However, lower ratings on HRQoL are not uncommon 
in chronic diseases (3). Patients with DM also report reduced HRQoL due to the skin 
manifestations, such as pruritis (78).  
In this thesis, the HRQoL was measured using the Short Form-36 (SF-36). The SF-36 
was developed because of an increasing consensus of the importance of considering the 
patients’ opinion of their health when evaluating medical care or the impact disease cause 
on health (79, 80). It also was intended to be a generic instrument that could be used to 
compare chronic diseases to a general population (80). The SF-36 was designed to be 
used as a measure in the Medical Outcomes Study (MOS) (79). The choice of 
dimensions included in the SF-36 was based on concepts in the most frequently used 
health measures (79). The areas chosen were Physical Functioning (PF), Role Physical 
(RP), General Health (GH), Social Functioning (SF), Role Emotional (RE), and Mental 
Health (MH). Two additional dimensions, Bodily Pain (BP) and Vitality (VT), were added 
based on results from empirical studies (79). These dimensions were assumed to be 
universal and would represent fundamental human functions and wellbeing (80). By 
comparing the SF-36 to other measurements used to assess general health, the SF-36 
has been found to include the eight dimensions that are most commonly included in these 
generic measures (81). In the general population, there is a gender difference where men 
rate their HRQoL better than women, especially in the Physical Functioning, Bodily Pain 
and Vitality dimensions (82). 
The ICF components of body function and structures, and activities and participations, 
including work/employment, are represented in different dimensions of the SF-36 (83, 84). 
The SF-36 corresponds additionally to a person’s wellbeing as it relates to health 
perception (83, 84). In patients with PM and DM, the HRQoL is rated lower in all 
dimensions of the SF-36 compared to the population norms, and interestingly, the HRQoL 
does not correlate to the disease course or muscle function (3, 4). 
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1.6 Rationale for this thesis 
Patients with PM and DM are classically described as having more proximal than distal 
weakness (7, 10). However, in a study conducted by our research group, we observed 
that disability due to distal weakness seemed to be a more common problem in patients 
with PM and DM (85) than previously described. Therefore, we wanted to investigate 
how and when hand function was affected. Since hand function is of importance when 
performing daily activities (36) and has been shown to be associated with HRQoL (86, 
87), we wanted to correlate these variables with hand function in patients with PM and 
DM. Hand exercise is a common treatment to improve or maintain hand function and 
activity in occupational therapy (49); therefore, we aimed to develop a hand exercise 
programme to test its feasibility and its possible effect on hand function and activity. 
Furthermore, since work ability is commonly affected in other rheumatic conditions (73, 
74) and work is essential for both the individual and society (67, 72) and also because 
there was limited information about work ability in patients with PM and DM, we 
investigated work ability. 
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2 Aim 
2.1 General aims 
The overall aim of this thesis was to describe and explore hand function, activity limitation, 
work ability, and HRQoL in patients with PM and DM. 
2.2 Specific aims 
The more specific aims were as follows: 
 To investigate hand function in PM and DM patients and compare it with 
reference values in healthy individuals and also to determine if hand function was 
correlated with activity performance and HRQoL (Paper I). 
 To compare patients with PM and DM to normative values from the literature 
regarding grip force and HRQoL at different time points up to six years after 
diagnosis to investigate how grip force changes over time and to correlate grip 
force with HRQoL (Paper II). 
 To develop a 12-week hand exercise intervention for patients with PM and DM and 
evaluate adherence, patient opinion of programme design and overall feasibility, 
hand function, and activity limitation after the intervention (Paper III). 
 To investigate the work situation, work ability, work-related risk factors, and 
influence of the physical and psycho-social work environment in patients with PM 
and DM (Paper IV).  
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3 Methods 
3.1 Study design 
This thesis employed a quantitative method with either cross-sectional, over time, or an 
intervention pilot design (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Methods, participants, and data analysis in Papers I-IV. 
n=number, PM=polymyositis, DM=dermatomyositis, SD=standard deviation, IQR=interquartile range. 
Paper IV 
Design: Observational and cross-sectional 
design 
Data collection: 2012-2013 
Study population: n=48 PM/DM patients  
Assessments: Functional assessments and 
questionnaires 
Data analysis: 
Descriptive (number, percentage, mean, SD, 
median, range, IQR) 
Comparative (Mann Whitney U-test) 
Correlations (Spearman’s correlation 
coefficient) 
Paper I 
Design: Observational and cross-sectional 
design 
Data collection: 2001 
Study population: n=31 PM/DM patients 
Assessments: Functional assessments and 
questionnaires 
Data analysis: 
Descriptive (mean, SD, median, IQR, CI) 
 
Comparative (independent-sample t-test, Mann 
Whitney U-test) 
Correlations (Pearson’s and Spearman’s 
correlation coefficient) 
Paper II 
Design: Observational, cross-sectional, and 
over time design 
Data collection: 2003-2012 
Study population: n=89 PM/DM patients  
Assessments: Functional assessments and 
questionnaire 
Data analysis: 
Descriptive (percentage, mean, SD, median, 
IQR) 
Comparative (Wilcoxon Signed-rank test (null 
hypothesis=no difference)) 
Correlations (Spearman’s correlation 
coefficient) 
Over time (Mixed linear model) 
Paper III 
Design: Pilot intervention  
study  
Data collection: 2010-2012 
Study population: n=11 PM/DM patients  
Assessments: Functional assessments and 
questionnaire 
Data analysis: 
Descriptive (numbers, percentage, mean, SD, 
median, IQR) 
Comparative (Wilcoxon Signed-rank test (null 
hypothesis=no difference)) 
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3.2 Patients 
Patients in all papers were recruited through the Swedish Myositis Network (SweMyoNet) 
Registry at the Rheumatology Department at Karolinska University Hospital in Stockholm. 
In Paper II, patients from Akademiska University Hospital in Uppsala and Falun Hospital 
in Falun were also included.  
In Papers I-IV, 143 patients were included (women, n=85 and men, n=58) with PM  
(n= 81) and DM (n=62). Most of the patients were included in one study (n=111, 62%);  
56 patients (31%) took part in two studies, and 12 patients (7%) participated in three 
studies. Patient demographics for Papers I-IV are presented in Table 2. 
 
 
Table 2. Demographics for the participants in Papers I, II, III, and IV. 
Demographics Paper I 
n=31 
Paper II 
n=89 
Paper III 
n=11 
Paper IV 
n=48 
Age (years), mean (SD) 56 (11) 60 (14) 63 (12) 54 (10) 
Disease duration (years), mean (SD)  7 (6) n/a 8 (7) 9 (9) 
Gender, women, n (%) 18 (58) 52 (58) 6 (55) 29 (60) 
Diagnosis, PM, n (%) 20 (65) 53 (60) 5 (46) 25 (52) 
n=number, SD=standard deviation, n/a=not applicable, PM=polymyositis. 
 
 
When the study reported in Paper I was conducted, 50 patients diagnosed with PM or 
DM were identified through the SweMyoNet Registry at the Rheumatology Clinic at 
Karolinska University Hospital in Stockholm, Sweden, and were informed about the 
study. 
Inclusion criteria were definite or probable PM or DM according to the diagnostic criteria 
by Bohan and Peter (12). Exclusion criteria for participation were other diseases or 
injuries that could affect hand mobility and grip force, such as other rheumatic or 
neurological diseases. The study included 31 patients (Table 2).  
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In Paper II, the cohort consisted of patients from three rheumatology clinics in Sweden 
(Falun, Stockholm, and Uppsala) who were identified through the SweMyoNet Registry. 
Data were collected between June 2003 and February 2012. Inclusion criteria for Paper II 
were patients diagnosed with definite or probable PM or DM (12) between 2003 and 
2012, with at least one recorded value between the time of diagnosis (year 0) and 6 years 
after diagnosis on either the grip force as measured by Grippit© (47) or HRQoL measured 
by SF-36 (80, 88). Exclusion criteria were other diseases or conditions that could affect 
hand function, such as arthritis. 
A total of 127 patients with PM or DM were identified. Thirty-eight patients were excluded 
as they did not have any grip force or HRQoL data recorded or because they had a 
coexisting condition (Figure 4). Finally, the study included 89 patients with PM and DM 
(Table 2).  
 
 
 
Figure 4. Paper II, flowchart for the patients in the SweMyoNet registry divided into the different 
aims. 
PM=polymyositis, DM=dermatomyositis, n=number, SF-36=Short Form-36. 
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In Paper III, the hand exercise intervention was introduced to a convenience sample of 15 
patients with PM and DM (probable or definite, according to Bohan and Peter’s criteria) 
(12) who were followed at the rheumatology clinic at Karolinska University Hospital in 
Stockholm and who had the following: 
 Reduced hand grip strength (≥20%) when compared to gender- and age-
matched normative values from the literature (47) (according to patient records)  
 Established disease (> 6 months)  
 Low disease activity (with conventional immunosuppressive treatment according 
to the choice of the treating physician)  
A total of 11 patients completed the hand exercise intervention (Table 2). 
In Paper IV, 78 patients with PM and DM at working age were identified through the 
SweMyoNet Registry at Karolinska University Hospital in Stockholm, Sweden, in June 
2012 and invited to participate in this study (Figure 5).  
Inclusion criteria in Paper IV were patients (a) diagnosed with probable or definite 
polymyositis and dermatomyositis (12) (b) who were 18-67 years of age, (c) and still alive 
in June 2012. Exclusion criteria eliminated patients who were (a) unable to read and 
understand questionnaires in Swedish, (b) on sick leave due to other causes than 
myositis, (c) studying, or (d) unemployed.  
The study included 48 patients with PM and DM (Table 2, Figure 5). 
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Figure 5. Paper IV, inclusion and exclusion of patients. 
PM=polymyositis, DM=dermatomyositis, n=number. 
 
 
3.3 Data collection procedure 
Patients included in this thesis have been identified through the SweMyoNet Registry, 
which is a national quality of care registry used in clinical practice. Patients are followed 
longitudinally, and measures are registered once a year, including disease activity, 
disease damage, and HRQoL, as suggested by the IMACS group (34). The measures 
are collected by a team made up of an occupational therapist, a registered nurse, a 
physical therapist, and a physician. There is also an international network regarding 
myositis that collects data in a registry with the aim to enable research on genetics and 
epidemiology. 
3.3.1 Paper I 
In Paper I, the data collection was done at one occasion. The same occupational 
therapist (M Regardt) assessed hand function, and the patients answered the self-
assessment questionnaires. 
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3.3.2 Paper II 
In Paper II, the data were retrieved from the SweMyoNet Registry. The data included 
follow-up measurements, grip force and HRQoL, patient characteristics at the time of 
diagnosis (age, diagnosis, and gender), medical treatment, and IMACS recommended 
outcome measures of disease activity (34). Missing information was retrieved from patient 
records when possible. As registry data were collected from clinical practice, a time lapse 
was discovered in some cases between diagnosis and the first measure (year 0). In 23% 
of the patients, there were no data on grip force or HRQoL from year 0. 
3.3.3 Paper III 
In Paper III, patients were assessed before and after the 12–week hand exercise 
intervention (Figure 6). The physician evaluated disease activity (according to the IMACS 
six-item core set (34)), the occupational therapist (Y Axelsson) assessed hand function 
(Jamar dynamometer, pinch meter, Grip Ability Test (GAT), Purdue Pegboard), and the 
patients answered the Disability of the Arm, Shoulder, and Hand (DASH) questionnaire to 
evaluate activity limitation (89, 90) (Figure 6). 
The hand exercise programme was introduced by a second occupational therapist, the 
author (M Regardt). The occupational therapist observed the patients performing the 
exercise to ensure that they were able to follow the programme and had understood how 
the exercises should be carried out. Patients were given the option of exercising at the 
hospital once a week and follow-up visits were done throughout the study either by 
phone, at the hospital, or both and were planned jointly by the patient and occupational 
therapist (M Regardt). The occupational therapist supervised the patients at the follow-up 
visits and checked the exercises to make sure that the programme was performed 
correctly. Patients were asked not to change their lifestyles or to start any other form of 
exercise during the study period, and this was confirmed at the end of the study. 
3.3.3.1 Hand exercise programme 
Since there is limited information about hand function and whether it affects activity in 
patients with PM and DM, a general hand exercise programme that included hand 
strengthening movements involved in accomplishing daily activities was designed.  
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The programme was based on hand- and finger-movements using personally adapted 
resistance putties (standardized doughs) {Royal putty [medium, light or x-lite (Mediroyal 
Nordic AB©, Stockholm, Sweden)] and Jura putty [medium soft (JURA Medical©, 
Glasgow, United Kingdom)]}. The putties were tested so that each patient could fully 
flex his or her fingers through the dough (91), and the patients were asked to evaluate 
subjectively whether the putty was “too soft”, “too hard”, or “just right”. If the dough were 
too hard or too soft, it was changed to another with more or less resistance or was 
mixed until it felt “just right”. When the patient could flex his or her fingers through the 
dough and it felt “just right”, he or she was asked to rate exertion on one of the 
movements in the programme [finger flexion, 30 repetitions (Figure 6)] using the Rating 
of Perceived Exertion (RPE) Borg Category Ratio (CR) 10 scale of exertion (92, 93). 
The occupational therapist (M Regardt) chose the putties based on a lower limit on the 
RPE Borg CR 10 scale, “moderate exertion” (≥ 3) (92, 93). The mean rating on the 
scale was “strong exertion” 5 (± 1.8), with the range being from 3 (“moderate”) to 8 
(“more than strong exertion”). The hand exercise programme was intended to be 
performed three times a week for 12 weeks (36 total times) and was illustrated by 
pictures from the Mobilus Professionals program (Mobilus Digital Rehab AB Sweden©, 
Gothenburg, Sweden). To facilitate improvement in strength, the number of repetitions 
increased every fifth week (91). Figure 6 provides further information about the hand 
exercise programme, the various movements, and the number of repetitions performed 
throughout the intervention. Patients kept diaries of their exercise, documenting each 
session performed, their ratings on the RPE Borg CR 10 scale (92, 93), and any 
comments they had about the programme. 
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Figure 6. Procedure in the hand exercise intervention and the hand exercise programme in Paper III. 
Figure 6 legend. Two sets of movements performed at every exercise session (three times per week for 12 weeks). 
§= 5 repetitions performed during week 1-4, 10 repetitions performed during week 5-8, and 15 repetitions performed during week 9-12.  
§§= 10 repetitions performed during week 1-4, 20 repetitions performed during week 5-8, and 30 repetitions performed during week 9-12, 
rep=repetitions. 
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3.3.4 Paper IV 
In Paper IV, an information letter was sent to eligible patients who were then contacted 
by phone. Patients who were working or had been on sick leave <2 years and who 
consented to participate in the study were interviewed in person at Karolinska 
University Hospital by an occupational therapist (M Regardt). Those individuals who 
had been on sick leave ≥2 years had the questionnaires and consent form sent to them 
by mail with a prepaid return envelope. If there were any unanswered questions, the 
occupational therapist (M Regardt) contacted patients by phone to give them the 
opportunity to complete the questionnaires. Information on disease activity at the time 
of the study was captured from the SweMyoNet Registry and assessed according to the 
International Myositis Assessment and Clinical Studies Group (IMACS) (34). 
3.4 Outcome measures 
In this thesis, outcome measures to assess hand function, activity limitation, work ability, 
HRQoL, and evaluation of a hand exercise intervention were used (Table 3). 
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Table 3. Outcomes used in this thesis and their connection to the ICF. 
Measure Characteristics of measure Paper ICF components and chapters 
Body functions Activities and 
participation 
Environmental 
factors 
Personal 
factors 
Grippit©  Grip force I-II  b7    
Jamar dynamometry Hand grip strength III b7    
Pinch meter Pinch grip strength III b7     
GAT Grip ability III  X   
Purdue Pegboard Dexterity III  d4   
EPM-ROM scale Range of motion I b7    
DASH Physical function and symptoms of the upper 
extremity 
III b1, b2, b7 d1, d2, d4, d5, d6, 
d7, d8, d9  
 X 
MAP Difficulty and importance of specific activities I   X   
WAI* Self-reported work ability IV b1, b2, b4, b5, b8 d8   
Work-related risk factors* Occurrence of work-related risk factors are present IV b7 d4   
WEIS* Perception of performance, satisfaction and wellbeing IV b1, b2, b7 d1, d2, d7, d8, d9 e1, e2, e3, e4  
SF-36 HRQoL I-II  b1, b2 d2, d4, d5, d6, d8, d9   
PF    d4, d5, d9   
RP    d2, d8   
BP   b2 d8, d8   
GH       
VT   b1    
SF   b1 d9   
RE   b1 d2, d8   
MH   b1    
GAT=Grip Ability Test, EPM-ROM= Escola Paulista de Medicina-Range of Motion, DASH=Disabilities of the Arm, Shoulder, and Hand, MAP=Myositis Activities Profile, WAI=Work Ability 
Index, WEIS=Work Environment Impact Scale, SF-36=Short Form-36, PF=Physical Functioning, RP=Role Physical, BP=Bodily Pain, GH=General Pain, VT=Vitality, SF=Social Functioning, 
RE=Role Emotional, MH=Mental Health, b1=Mental functions, b2=Sensory functions and pain, b7= Neuromusculoskeletal and movement-related functions, d1= General tasks and demands, 
d2=Learning and applying knowledge, d4=Mobility, d5= Self-care, d6= Domestic life, d7= Interpersonal interactions and relationships, d8=Major life areas, d9=Community, social, and civic 
life, e1=Products and technology, e2= Natural environment and human-made changes to environment, e3=Support and relationships, e4=Attitudes, X= the measure has a link to the 
component, *=In the column of measures subjective linking to the ICF component by the author M Regardt. 
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3.4.1 Hand function 
3.4.1.1 Grip force and hand grip strength 
Grip force and hand grip strength were measured separately in the right and left hands by 
either the Grippit© (Detektor AB, Göteborg, Sweden) or the computer-connected Jamar 
dynamometer (Biometrics E-link H 500 hand kit) (47, 48). The former measure (Grippit©) 
has been suggested to be a reliable measure of grip force in patients with myositis (94). 
These measure of grip force and hand grip strength are linked to the ICF component body 
functions (95, 96) (Table 3). In the general population, there is a difference in grip force 
and hand grip strength between women and men; therefore, the analysis was done on 
women and men separately (47, 48). 
The Grippit© was used in Papers I and II and is an electronic measure that gives 
maximum, mean, and final values after a period of 10 seconds and measures in 
Newtons (N) (47). Measurements are recorded every half second during the 10-second 
test, and the higher the score, the better the grip force. Mean values over 10 s have 
been used in the analysis. Normative values on grip force based on gender and age 
were available from a Swedish cohort of healthy individuals (47). 
The Jamar dynamometer is a computer-connected device used to measure hand grip 
strength in kg, and it was used in Paper III (Biometrics E-link H 500 hand kit) (48). The 
average of three measures for each hand was used in the analysis. Normative data from 
a population-based study for women and men in different age groups are available for 
comparison (48). A minimal significant change of at least 6 kg indicated a clinically 
meaningful improvement (97). 
3.4.1.2 Pinch grip strength 
The computer-connected Biometrics pinch meter was used to measure pinch grip 
strength separately in the right and left hands (kg) (Biometrics E-link H 500 hand kit) in 
three positions: key (lateral), three-jaw (tri-pod), and thumb to index finger opposition (tip-
to-tip) (Paper III). Three trials were performed per position, and the average value per 
position for each hand was used in the analysis. The literature contains no comparable 
normative values or guidelines on what could be considered a clinical improvement in the 
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Biometrics pinch meter (Biometrics E-link H 500 hand kit) since it has a thinner profile 
design than a regular pinch gauge meter. Therefore, the definition that IMACS suggested 
for clinically meaningful improvement in muscle strength and physical function (≥15%) 
was used in Paper III (98). Pinch grip strength has been linked to the ICF component 
body function (95, 96) (Table 3). 
3.4.1.3 Grip ability  
The Grip Ability Test (GAT) (99) was used to measure grip ability in Paper III. The GAT 
includes three grips that patients perform at one time. The faster they complete the test, 
the better their score and grip ability. The three grips include putting a sock over the non-
dominant hand, putting a paperclip on an envelope, and pouring water from a 1-litre jug 
into a cup. In the literature, the average mean for healthy controls was 16.5 s, and a value 
<20 was regarded as a normal grip ability (99, 100). The GAT is linked to the ICF 
component activities (100) (Table 3). There is no recommendation on what is considered 
a clinically meaningful improvement in GAT. Therefore, the definition suggested by 
IMACS for clinically meaningful improvement in muscle strength and physical function 
(≥15%) was used in Paper III (98). 
3.4.1.4 Dexterity  
The Purdue Pegboard was used in Paper III to measure dexterity (101). The Purdue 
Pegboard includes two parts; in the first part, patients put as many pegs as possible on 
a board in 30 seconds using only one hand at a time. In the second part, patients have 
60 seconds to manipulate pegs, collars, and washers (assembly) onto the board. The 
more pegs, collars, and washers the patient places on the board, the better the 
dexterity (101). The test was done three times, and the average of the three trials was 
used in the analysis. For comparison, the literature contains normative values based on 
convenience sampling (101). A repeatability test on the Purdue Pegboard has been 
conducted on another muscle-affecting diseases (muscular dystrophy), suggesting a 
true difference of two or three pegs (102). Based on these results, improvement 
considered to have a clinically meaningful difference was set to ≥3 in Paper III. 
Dexterity measured by the Purdue Pegboard is linked to the ICF component activities 
(95) (Table 3). 
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3.4.1.5 Hand joint mobility 
The Escola Paulista de Medicina-Range of Motion (EPM-ROM) scale was used to 
evaluate joint mobility in Paper I (103). The EPM-ROM scale measures active joint 
mobility with goniometry in seven joints. Only joints involving the hand were measured 
(wrist, thumb, and the MCP joints). The range of mobility varies from 0 to 3, where 0 is 
equivalent to full mobility and 3 indicates severe joint mobility limitations. The final score 
is calculated through the sum of the values on the right and left sides and is then 
divided by 2. This calculation gives a scale from 0 to 21, where 0 indicates good joint 
mobility and 21 indicates severe joint mobility limitation (103). Joint mobility is linked to 
the ICF component of body function (96) (Table 3). 
3.4.2  Activity limitation 
Activity limitation has been evaluated by either the DASH questionnaire (Paper III) (89, 
90) or the Myositis Activities Profile (MAP) (Paper I) (104).  
The DASH is a 30-item questionnaire designed to measure physical function and 
symptoms in people with any or several musculoskeletal disorders of the upper limb 
(105). Patients self-rate their ability on a five-grade scale ranging from no difficulty (1) to 
impossible to do (5). Scores were calculated with a range from 0–100, and a higher 
score indicated greater activity limitations. For comparisons, the literature contains 
normative values from the general population (90). In the DASH questionnaire, a 
minimal important change of at least 10 points was considered a clinically meaningful 
improvement in Paper III (105). The questions in DASH are linked to the ICF 
components of body function, activities, and participation and also to personal factors 
(106) (Table 3). 
The MAP is a disease-specific questionnaire measuring difficulty in performing the 
activities of daily life during the past week (104). Difficulty is defined as how hard the 
activity is to perform and how important the activity is for the person to manage. Each 
activity is scored on a 7-point scale (where 1 indicates no problem and 7 indicates 
impossible to do). The activities are divided into four sub-scales: movement activities, 
activities of moving around, self-care activities, and domestic activities. The questions 
are ordered in rank, and the median value and quartiles for every sub-scale are used in 
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the results. Four additional single items are included in the MAP regarding social 
activities, avoiding over-exertion, work/school work, and leisure activities, which are 
presented in the results as the actual score (104). The MAP was developed based on 
the International Classification of Impairments, Disabilities, and Handicaps (ICIDH)-2 
Beta-2 draft and has connections to the ICF component of activities and participation 
(104) (Table 3). 
3.4.3 Work Ability  
Self-rated work ability was assessed by the Work Ability Index (WAI) in Paper IV (107, 
108). The WAI is a questionnaire that contains seven items (10 questions) that are rated 
on different scales. One example of the questions concerns the principal demands at 
work (psychologically demanding, physically demanding, or a combination of both) (107). 
A sum score can be calculated by summing up the seven items to a total WAI score in the 
interval of 7-49. A total WAI score of 7-27 indicates poor work ability (restore work ability). 
A score from 28-36 suggests moderate work ability (improve work ability), while a score in 
the range of 37-43 indicates good work ability (support work ability). Excellent work ability 
is represented by a score of 44-49 (maintain work ability) (107, 109). The WAI has not 
been linked to the ICF components in a standardized way. Based upon a subjective 
linking to the ICF components by the author (M Regardt), the WAI seems to have links to 
body functions and structures and in the ICF component of activities and participation, 
which includes work (21) (Table 3).  
3.4.4 Work-related risk factors 
To assess work-related risk factors in Paper IV, the Swedish Work Environment 
Authority’s statute book (AFS) provision AFS 1998:1, Ergonomics for the Prevention of 
Musculoskeletal Disorders, was used (110). Eleven questions were selected based on 
hand function and the symptoms of proximal muscle weakness and reduced endurance 
that are common in PM and DM (7, 10, 111). Self-rating questions concerning work-
related risk factors were addressed by asking how often prolonged or recurrent work is 
done with the arm and shoulder, with the neck and back bent, doing fatiguing leg work, 
with exhaustive manual lifts, and carrying or repetitive work movements. The questions 
were answered by the patients on a four-point scale with rating steps ranging from 
“never” to “very often”. Based upon a subjective linking, by the author (M Regardt), the 
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questions regarding work-related risk factors seems to have links to the ICF 
components body functions and activities and participation (21) (Table 3). 
3.4.5 Work Environment 
The semi-structured interview instrument Work Environment Impact Scale (WEIS) was 
used in Paper IV to assess how the individuals experience and perceive their work 
environment (112). When using the WEIS, it is mandatory to have a job to relate to. 
Therefore, we chose to perform this measure on the patients who had been working at 
some point within the last two years (n=38). The WEIS contains 17 items, which reflect 
upon the client’s own perception of opportunities and constraints in the work environment 
related to social groups, physical spaces, objects, and tasks (113). There is an interview 
guide to follow, and complementary questions are used when necessary. After the 
interview, the assessor rates the 17 items on a four-point rating scale. Ratings 1 and 2 
indicate that the item “strongly interferes” or “interferes” with the individual’s work 
performance, satisfaction, and physical/emotional/social wellbeing, while 3 and 4 imply 
that the item “supports” or “strongly supports” the individual’s work performance, 
satisfaction, and physical/emotional/social wellbeing (112). The environmental factors that 
interfere and/or provide support are concluded in a summary based on the 17 items. The 
WEIS was developed from an occupational therapy model, the Model of Human 
Occupation (MoHO) (114). According to the model, the environment gives both 
opportunities for behaviour but also presses for certain demands of an individual (70). 
The WEIS does not assess the environment but instead evaluates its effect on a 
person’s performance (114). The environment’s impact on a person depends on the 
person’s values, interests, personal caution, habits, roles, and performance (70). 
There has not been any standardized linking between the items in the WEIS and the 
components in the ICF. Based upon subjective linking by the author (M Regardt), the 
WEIS seem to have links to the ICF components of body functions, and activities and 
participation as well as in the environmental factors (21) (Table 3). However, there were 
questions that did not appear to be connected to the ICF, such as questions related to 
time and expectations of demands. 
  31 
3.4.6 Health-related quality of life 
In Papers I and II, the HRQoL was evaluated by the patient-reported questionnaire SF-36 
(80, 88). The SF-36 contains questions relating to both physical and mental aspects of 
self-experienced HRQoL in eight dimensions. The eight dimensions are Physical 
Functioning (PF), Role Physical (RP), Bodily Pain (BP), General Health (GH), Vitality 
(VT), Social Functioning (SF), Role Emotional (RE), and Mental Health (MH) (80, 88). The 
dimensions are scored on a scale ranging from 0 to 100, with 100 indicating excellent 
HRQoL. Gender- and age-matched values for the Swedish general population in the 
literature were used for comparisons (80). The questions in SF-36 are linked to the ICF 
components body function and activities and participation (84, 115, 116) (Table 3). 
3.4.7 Evaluation of the hand exercise programme 
The hand exercise intervention (Paper III) was evaluated using adherence, exertion, 
and patients’ opinion about the design of the hand exercise programme. Adherence 
was defined as the completed number of exercise sessions performed compared with 
the expected number (36). This information was collected from patients’ exercise 
diaries. An acceptable adherence was ≥75% (≥ 27 sessions). The hand exercise 
programme was evaluated based on patients’ exertion rating using the RPE Borg CR 
10 scale after every session (92, 93). In addition, patients were asked their opinions 
about the programme, the frequency, and the overall feasibility of undertaking the hand 
exercises. 
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3.5 Data analysis 
A summary of the different statistical analyses performed in this thesis is presented in 
Table 4. 
 
 
Table 4. Summary of statistical analyses performed in Papers I-IV. 
Methods Paper I Paper II Paper III Paper IV 
Mean (SD) X X X X 
Mean (CI) X    
Mean difference (CI)  X   
Median (IQR) X X X X 
Percentage X X X X 
Number X X X X 
Range    X 
Independent sample t-test X   X 
Mann-Whitney U-test X   X 
One sample t-test 95% CI X    
Pearson’s correlation coefficient X    
Spearman’s correlation coefficient X X  X 
Wilcoxon Signed-rank test  X X  
Mixed linear model  X   
Bonferroni after test  X   
Effect size   X  
SD=standard deviation, CI= Confidence intervals, IQR=Interquartile Range. 
 
 
3.5.1 Paper I 
To describe grip force, hand mobility, activity limitation, HRQoL, and disease activity, 
mean, standard deviations (SD), median, Interquartile Range (IQR), confidence 
intervals (CI), independent-sample t-test, and Mann Whitney U-tests have been used. 
Mean values, one-sample t-test, and CIs were employed to compare patients with PM 
and DM to gender- and age-matched normative values regarding HRQoL using SF-36 
(80) and grip force using Grippit© (47). The mean value for the normative values was 
determined by collecting a gender- and age-matched mean value for each patient and 
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then calculating a new mean value for the reference group. The differences between 
patients with PM and DM and also between women and men regarding grip force, hand 
mobility, activity limitation, and HRQoL were analysed by mean values, independent 
sample t-tests, and Mann Whitney U-tests. Pearson’s correlation coefficient, respective 
Spearman’s r mean values, and CIs were used to calculate correlations between hand 
mobility and grip force with regard to the variables’ activity limitation, HRQoL, disease 
activity, and disease duration. All statistical calculations were made using the Statistical 
Package for the Social Sciences (SPSS; Chicago, IL, US) version 15. The level of 
significance was set to ≤0.05. 
3.5.2 Paper II 
The study used number, percentage, median, Interquartile Range (IQR), mean, and 
standard deviations (SD) to describe the characteristics of patients at disease onset. 
The Wilcoxon Signed-rank test was applied to assess cross-sectionally if there were 
differences in grip force (47) and HRQoL (80) among patients diagnosed with PM and DM 
at different times (time of diagnosis (Year 0) to 6 years after diagnosis) as compared to 
normative values for healthy individuals or the Swedish population in general in the 
literature (null hypothesis = no difference between PM and DM distribution and normative 
values). For each patient, a gender- and age-matched value was collected from the 
literature based on healthy individuals (for Grippit©) or from the general population (for 
SF-36) (47, 80). These values represent the sample of normative values used in this 
study. Observed values for patients with PM and DM were standardized using gender- 
and age-specific normative values (mean and standard deviation) in the literature (47, 
80). The significance level was set to ≤0.05, and in the analysis on grip force, it was 
adjusted by the Bonferroni after test. To describe how many of a patient’s grip force 
values were lower than normative values, the study compared them to standard deviation 
(47) and error of measurement (94) adjusted values and presented as percentages. 
The mixed linear model was used to investigate how grip force changed over time with 
year 0 (time of diagnosis) and years 1, 2, 3, 4, 5, and 6 after diagnosis as repeated 
measurements. The mixed linear model enabled comparisons longitudinally when 
subjects had missing values at any given time-point (117). The study analysed potentially 
influential factors (disease duration, gender) for main effects and possible interaction 
effects. Comparisons among factors over time were adjusted by the Bonferroni after test. 
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Mean difference and CI were used to describe differences. The significance level was set 
at ≤ 0.05. 
The Spearman correlation coefficient (rs) was used to assess correlations between grip 
force and HRQoL at different times (year 0 and years 1, 2, 3, 4, 5, and 6 years after 
diagnosis). The correlation coefficient was set to rs ≥ 0.6, and a Bonferroni-adjusted 
significance level of ≤ 0.0036 was considered significant. According to Munro (1997), 
correlation coefficients between 0 and 0.25 are considered to have no or very low 
correlation, coefficients between 0.26–0.40 have a low correlation, coefficients between 
0.41–0.69 have a moderate correlation, coefficients between 0.70–0.89 have a high 
correlation, and coefficients between 0.90–1.0 have a very high correlation (118).  
All analyses on grip force (Grippit©) (47) were performed on both the right and left hands. 
All statistical calculations were made using the IBM Statistical Package for the Social 
Sciences (SPSS) version 19 (Armonk, NY, USA). 
3.5.3 Paper III 
Patient characteristics, adherence, disease activity, medical treatment, measures of hand 
function (hand grip strength, pinch grip strength, grip ability, and dexterity) and activity 
limitation are presented as numbers, percentages, means, standard deviations (SD), 
median (md) and interquartile ranges (IQR). The Wilcoxon Signed-rank test was used to 
analyse differences at baseline between patients with PM and DM and normative values 
from the general population or healthy individuals from the literature regarding hand grip 
strength (Jamar) (48), grip ability (GAT) (99), dexterity (Purdue Pegboard) (101), and 
activity limitation (DASH) (90) (null hypothesis = no difference between PM and DM 
distribution and normative values). The observed values for patients with PM and DM 
were standardized using gender- and age-specific normative values from the general 
population or healthy individuals (mean and standard deviation) from the literature (48, 
90, 99, 101). 
The Wilcoxon Signed-rank test was used to analyse differences between baseline and 
follow-up in hand function (hand grip strength, pinch grip strength, grip ability, and 
dexterity), activity limitation, disease activity, and medical treatment. Effect size was used 
to evaluate the responsiveness defining values from 0.2–0.5 as a low level of 
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responsiveness, values from 0.51–0.8 as moderate, and values > 0.81 as a high level of 
responsiveness (97). 
Individual differences between baseline and follow-up have been described and 
meaningful change evaluated based on respective measures and, if not applicable, the 
IMACS-suggested definition of clinically meaningful improvement in muscle strength and 
physical function (≥15%) has been used (98). The significance level for all analyses was 
≤0.05. All statistical calculations were made using the IBM Statistical Package for the 
Social Sciences (SPSS) version 19 (Armonk, NY, USA). 
3.5.4 Paper IV 
To describe demographics, work situation, self-rated WAI, work-related risk factors, and 
the WEIS, this study used mean, standard deviation (SD), median, IQR, range, number, 
and percentage.  
The Mann Whitney U-test or independent sample t-test was employed for group 
comparisons regarding demographics, work situation, self-rated WAI, and work-related 
risk factors. The Spearman’s rho was used for calculations of correlation between self-
rated work ability (total WAI score) and percentage of full-time employment, work-related 
risk factors, and also the work environment (WEIS). Spearman correlation coefficients 
between 0 and 0.25 were considered as no or very low correlation, 0.26–0.40 as low 
correlation, 0.41–0.69 as moderate correlation, 0.70–0.89 as high correlation, and 0.90–
1.0 as very high correlation (118). For all statistical calculations, the Statistical Package 
for the Social Sciences (SPSS; Chicago, IL) version 19 was used. A statistical 
significance level of ≤ 0.05 was defined. 
3.6 Ethical considerations 
All papers were approved by the regional ethical review board. In Paper I, patients gave 
oral consent to participate, which was the requirement of the ethical committees in 
Sweden at the time of the study. In Papers II-IV the patients gave written consent to 
participate, in accordance with the Declaration of Helsinki (119). The patients were 
reassured that if they chose not to participate, their care at the Karolinska University 
Hospital would not be affected. 
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4 Results and discussion 
4.1 Hand function in patients with PM and DM  
(Papers I, II, and III) 
In this thesis, we aimed to investigate and explore different aspects of hand function in 
patients with PM and DM.  
Results from Paper I demonstrate that both women and men with PM and DM have 
reduced grip force compared to gender- and age-matched healthy individuals from a 
Swedish cohort (p<0.001) (120). The measure of hand grip strength or grip force is linked 
to the ICF component of body function. Patients with PM and DM are typically described 
as having proximal muscle weakness in the upper and the lower extremities, whereas 
measures of strength in the distal muscles are rarely included in recommended outcome 
measures, such as the manual muscle test in eight muscle groups (MMT-8) proposed by 
IMACS (7, 34). In this study (Paper I) we could, for the first time, demonstrate that hand 
grip strength and grip force may be negatively affected in up to 77% of patients with PM 
and DM (120). This was a cross-sectional study, and we used the conventional measure 
of grip force (Grippit©) (47, 120). This study raised the question of whether low grip force 
was already present at the time of diagnosis or if the impaired grip force develops during 
the disease course, as well as if it is reversible with conventional treatment. This was the 
background for Paper II, in which we did indeed confirm low grip force at the first visit at 
the time of diagnosis in about 92% of women and 93% of men with PM and DM when 
compared to normative values from gender- and age-matched healthy individuals from a 
Swedish cohort (Paper II) (47). This is novel information that can be added to the 
previously suggested effect on fine motor skills and distal muscles in the late phase of PM 
and DM disease (39, 121). In over time analysis in Paper II, the total group of patients 
improved in grip force from time of diagnosis to one or two years after (Paper II). 
In our studies (Paper I-III), we could also confirm reduced strength in the hand muscles by 
using two different measures: hand grip force (Grippit©) and hand grip strength (Jamar) 
(47, 48). Both measures gave comparable results, thus confirming reduced strength in the 
distal muscles of the upper extremities (Paper II) (120, 122).  
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The presence of weakness in distal muscles has previously been suggested in both the 
wrist flexion/extension and the ankle dorsi/plantar flexion by using the MMT, which 
suggested the proximal weakness was more pronounced than the distal weakness in 
patients with PM and DM (123). In that study, most of the patients (82-94%) had no or 
only mild limitation in wrist flexion and extension (123). In this thesis, the measures of 
strength in the distal muscles were limited to the hands, as assessed by measuring the 
grip force (Grippit©) or the hand grip strength (Jamar) (47, 48) (Paper II) (120, 122). The 
hand grip strength was measured by asking the patients to squeeze (flexing fingers) as 
hard as they could on a cylinder-shaped measure either three times (Jamar) (peak 
strength) (48) or by using the grip force by holding the grip for 10 seconds (Grippit©) 
(endurance to maintain power) (47). Even though some muscles are involved in both 
finger flexion (Grippit© and Jamar) and wrist flexion (MMT), these measures are not 
comparable since they measure different entities. Furthermore, MMT may be a less 
sensitive measure to identify mild distal impairment (98). Muscle weakness in the distal 
muscles of the lower extremity (heel and toe lift) have also been shown in patients with 
PM and DM (94). Since there were no significant differences in grip force between 
patients with PM and DM, these diagnoses were analysed together (120). 
When we assessed grip force at different time-points after diagnosis we found that the 
women with PM and DM had reduced grip force not only at diagnosis but also six years 
after diagnosis compared to the normative values for healthy individuals in the literature 
(Paper II) (47) (Table 5). In contrast to the women, the men had low grip force in both 
hands at diagnosis and up to two years after diagnosis (Paper II). In men, there were no 
additional significant differences at other time-points after diagnosis (Table 5) (Paper II). 
These observations suggest that grip force might have different patterns over time in 
women and men. Somewhat contradictory, the results of the over time analysis on grip 
force (Paper II) did not show any significant interaction between gender and disease 
duration in patients with PM and DM in relation to grip force, suggesting that women and 
men with PM and DM did not change differently over time (Figure 7) (Paper II). However, 
the number of observations after two years was low, particularly in the male group, 
making data after two years less reliable.  
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Table 5. Grip force in women and men with PM and DM in the registry compared to gender- and 
age-matched normative values of healthy individuals from the literature (47). Grip force is 
presented for both the right and left hand, respectively, and years since the diagnosis. 
Disease duration 
(years) 
Grip force (N) in women 
with PM/DM, n=47 
Grip force (N) in women 
normative values, n=105a 
Percentage of 
normative values (%) 
Right hand Md IQR Md p-value Md 
0, n=36 109 72-154 206 <0.001 54 
1, n=20 130 103-184 206 0.001 60 
2, n=20 112 79-164 206 0.001 57 
3, n=16 134 81-144 206 0.001 60 
4, n=11 161 75-201 197 0.013 69 
5, n=5 148 51-225 197 0.138 69 
6, n=7 111 75-168 197 0.018 56 
Left hand      
0, n=36 85 59-134 194 <0.001 49 
1, n=21 137 86-202 194 0.010 61 
2, n=20 100 70-148 194 <0.001 51 
3, n=16 107 77-128 194 0.001 56 
4, n=11 113 48-173 173 0.008 61 
5, n=5 114 32-176 173 0.080 53 
6, n=7 93 83-125 173 0.018 51 
Disease duration 
(years) 
Grip force (N) in men 
with PM/DM, n=32 
Grip force (N) in men 
normative values, n=64a 
Percentage of 
normative values (%) 
Right hand Md IQR Md p-value Md 
0, n=26 211 138-276 386 <0.001 52 
1, n=10 311 253-398 418 0.017 78 
2, n=11 329 196-366 386 0.016 85 
3, n=7 261 250-368 386 0.028 65 
4, n=4 257 192-347 402 0.068 63 
5, n=4 328 192-416 402 0.068 79 
6, n=3 319 n/a 418 0.109 83 
Left hand      
0, n=27 203 133-251 334 <0.001 57 
1, n=10 324 231-368 386 0.037 88 
2, n=11 290 169-333 334 0.013 83 
3, n=7 220 187-313 334 0.043 56 
4, n=4 238 121-354 360 0.144 64 
5, n=4 289 182-424 360 0.144 81 
6, n=3 301 n/a 386 0.285 80 
PM=polymyositis, DM=dermatomyositis, N=Newton, n=number, Md=median, IQR=Interquartile Range, 
a=Nordenskiold and Grimby 1993 (13), p-value=probability value, n/a=not applicable 
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Figure 7. Grip force in the right and left hand in women (о) and men (Δ) with PM and DM over 
time. a=regression line, b=There was no interaction between gender and time, indicating that the 
grip force did not change differently over time in women and men with PM and DM. 
Right hand 
a a 
Time * gender (p=0.769)b 
n=40 
Left hand 
a 
a 
Time * gender (p=0.912)b 
n=40 
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There could be several explanations for the reduced grip force in patients with PM and 
DM. One possibility is that a high disease activity affects general health in the early active 
disease phase, causing an impact on grip force (87). Another possibility is that muscle 
weakness in the proximal muscles of the arm could contribute to the lower grip force, 
suggesting that the proximal weakness may lead to a changed activity repertoire in the 
daily life of patients with myositis. Such a change in activity performance may result in 
reduced use of the whole arm, which can have a negative influence on grip force as a 
consequence. This hypothesis could not be tested in our studies since we did not include 
assessments of strength in the proximal arm muscles. Yet another possibility that cannot 
be excluded is that the disease may impact the distal muscles that affect grip force, but 
this hypothesis requires further explorations.  
In this thesis, hand functions were investigated using hand grip strength or hand grip force 
on a body function level as well as measures of pinch grip strength, grip ability, dexterity, 
and hand joint mobility with links to the ICF components body function, and activity and 
participation. Our results indicated only a small limitation in joint mobility in patients with 
PM and DM by the score of 3 out of 21 (0=good joint mobility) (120). In the hand 
exercise intervention study (Paper III), the patients with PM and DM had reduced dexterity 
compared to normative values from the literature at baseline (101, 122). This pilot study 
included a small convenience sample of patients with reduced hand grip strength, which 
may have caused a selection bias that could have influenced the result (122). However, in 
a previous study with the aim to evaluate the associations between grip strength and 
dexterity in healthy individuals, only a low correlation was found between these two 
measures (124). In that study, only 16% of the variety in grip strength was related to the 
variation in dexterity (124), indicating that patients with PM and DM may have impaired 
dexterity (122). However, this finding needs to be explored further in a larger cohort of 
patients. 
One recent report indicates that arthritis in the wrist and finger joints is more common in 
patients with PM and DM than earlier described (40); arthritis in the hands is known to 
impair and limit hand function (41, 42). Therefore, since the aim was to describe and 
evaluate impaired hand function due to muscle weakness, patients with arthritis or other 
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conditions that could affect hand function were excluded from our studies to avoid a 
potential influence of arthritis on hand function in Papers I-III (120, 122). 
4.2 Activity limitations in patients with PM and DM 
(Papers I, III, and IV) 
Next we investigated what activities patients with PM and DM perceived as difficult and if 
they correlated with grip force.  
Patients with PM and DM rated their activity performance from slightly difficult to very 
difficult in Paper I (120). Activities of moving around, work, and leisure were reported as 
the most difficult to perform (120). These results were confirmed in the hand exercise 
intervention (Paper III) where the participants had significantly more activity limitation 
(regarding the upper extremity), as measured by DASH, compared with normative 
values based on the general population from the literature (90, 122). 
The measures of activity limitation in this thesis have links to the ICF components body 
function, and activities and participation, as well as to personal factors. In patients with 
PM and DM, the reduced grip force was associated to domestic activities measured by 
MAP (Paper I) (120). Thus, a reduced grip force may increase activity limitation in 
domestic activities in patients with PM and DM (120).The results on activity limitation in 
the hand exercise study (Paper III) are based on patients with reduced hand grip 
strength, which is known to affect activity performance in other rheumatic diseases (45, 
125). In general, patients with PM and DM are affected in their activities due to the muscle 
weakness and reduced muscle endurance in the proximal muscles, leading to difficulties 
rising from a chair, walking up stairs, or combing their hair (33).  
Our results add knowledge that the activity performance may be affected by muscle 
weakness in the distal muscles as well (122). Activity limitation has been studied to 
evaluate pharmacological treatment in patients with PM and DM (126). That study 
showed that patients with PM and DM had limitations in their daily activities with a value 
of approximately 20 points on a scale from 0-45, where 45 points indicates no difficulty 
(126). In Paper I, work was one of the activities rated as most difficult by the patients with 
PM and DM and is in general an important aspect of activity both for the individual and for 
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society (67, 120). Therefore, we aimed to investigate the work ability in patients with PM 
and DM in Paper IV. 
4.2.1 Work ability in patients with PM and DM 
In paper IV we investigated work ability in 48 patients with PM and DM. Most of the 
patients had been working during the past two years and 36 out of 38 were working at the 
time of the study. The 10 patients who had been on sick leave ≥2 years had a range of 
sick leave between 34−162 months. In the whole group, 44% were working full-time (40 
hours/week), 31% worked part time, and 25% were on full-time sick leave. Even though a 
large proportion of the patients with PM and DM were working, 62% reported poor or less 
good self-rated work ability (Table 6) (Paper IV).  
 
 
Table 6. Self-rated work ability measured by WAI in patients with PM and DM. 
Work Ability Index (WAI)  Patients, 
n=48 
Patients (working 
or on sick leave <2 
years) n=38 
Patients (on sick 
leave ≥2 years) 
n=10 
Mann-Whitney 
U-test 
 
 n (%) n (%) n (%) z p-value 
Total WAI score    -2.5 0.01 
 Poor (Restore) 16 (33) 6 (16) 10 (100)   
 Less good (Improve) 14 (29) 14 (37) 0 (0)   
 Good (Support) 11 (23) 11 (29) 0 (0)   
 Excellent (Maintain) 7 (15) 7 (18) 0 (0)   
Sickness absences during the 
last 12 months (question 6) 
     
 None  10 (21) 10 (26) 0 (0)   
 1-7 days  5 (10) 5 (13) 0 (0)   
 8-24 days  13 (27) 13 (34) 0 (0)   
 25-99 days  5 (10) 5 (13) 0 (0)   
 100-365 days  15 (31) 5 (13) 10 (100)   
n=number, %=percent, p-value=probability-value 
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No previous studies have addressed the self-rated work ability in patients with PM and 
DM. In other rheumatic diseases, work ability is often impaired (127-129). The measures 
used in this thesis to assess different aspects of work have links to the ICF components of 
body function, and activities and participation as well as environmental factors. A poor 
self-rated work ability predicts disability pension (71) and might therefore be important to 
assess and possibly include in a rehabilitation programme for patients with PM and DM. 
Patients with PM and DM who had been on sick leave ≥2 years had more work-related 
risk factors than those who were still working. Work-related risk factors, such as heavy 
and prolonged or non-varied loads, can generate work-related musculoskeletal disorders 
(130) caused by a repetitive overload of the body (110). The areas of questioning were 
selected based on both the use of hand strength as well as the symptoms of proximal 
muscle weakness and reduced endurance that are common in PM and DM (7, 10, 111). 
We found that patients on sick leave ≥2 years had more work tasks that included 
prolonged or recurrent work with arm/hand stretched forward, the use of hand-held 
machines, working with pedals, and walking long distances (Table 7) (Paper IV). These 
results indicated that the patients were affected in their ability to work by the 
manifestations of the disease and suggested that patients with these types of work-
related tasks may benefit from an analysis of their work situation and specific support to 
enhance their ability to continue working (Paper IV).  
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Table 7. Work-related risk factors (based on Authority’s statute book (AFS) provision 1998:1a) in 
patients with PM and DM. 
 Patients 
n=48 
Patients 
working or on 
sick leave <2 
years, n=38 
Patients on 
sick leave 
≥2 years, 
n=10 
 
Work-related risk factors Quite to 
very often  
% 
Quite to very 
often  
% 
Quite to very 
often  
% 
p-
valueb 
Repeating similar working movements 79 79 80 0.94 
Prolonged or recurrent work:     
Arm/hand     
Above shoulder height 38 21 66.7 0.22 
Stretched forward 56 47 90 0.02 
Forceful movements and uncomfortable 
hand position/grips 
40 34 60 0.18 
Hand-held machines or tools 23 18 40 0.05 
Legs     
Repeated raising to ladder and squatting 38 34 50 0.37 
Work with pedals, walking stairs and long 
distances 
38 26 80 0.002 
Neck and back     
Neck bent forward, backwards, sideways, 
or/and twisted repeatedly or for long periods 
of time 
54 50 70 0.26 
Back bent forward, backwards, sideways, 
or/and twisted repeatedly or for long periods 
of time 
40 35 60 0.14 
Lifting and carrying     
Repeated exhaustive manual lifts 44 39 60 0.25 
Uncomfortable carrying, pushing, or pulling 
of loads 
27 24 80 0.31 
PM=Polymyositis, DM=Dermatomyositis, n=number, %=percentage, p=probability, a= Ergonomics for the 
Prevention of Musculoskeletal Disorders, (1998) 
(http://www.av.se/dokument/inenglish/legislations/Models_for_assessment.pdf), b= Mann-Whitney U-test 
was used to test for statistically significant differences between patients working or on sick leave <2 years 
and patients on sick leave ≥2 years.  
 
 
We also investigated how the work environment may impact the work ability in patients 
with PM and DM. Using the semi-structured interview instrument WEIS, patients with PM 
and DM reported that the work environment both “supported” them and “interfered” 
(Paper IV) (Figure 8). The items in the WEIS instrument perceived as “interfering” with 
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work performance, satisfaction, and physical/emotional/social wellbeing were Task 
Demands, Rewards, and Time Demands (Paper IV). This result is in agreement with an 
earlier Swedish study that included patients with a broad range of musculoskeletal system 
and connective tissue disorders as well as mental and behavioural disorders that had 
taken sick leave (131). Further, the WEIS items Interaction with Others and Meaning of 
Work were seen as “support” in both the previous and the present study (Paper IV) (131). 
The highly rated “support” in the work environment regarding interaction with co-workers 
and others might explain why so many of the patients working or on sick-leave for less 
than two years were working full-time and only had used a few days of sick leave (Table 
6) (Paper IV). These results emphasise the importance of the “social” working 
environment for patients with PM and DM. Support at the workplace has been described 
as important in improving work participation in patients with musculoskeletal conditions 
(132), and this might be true for patients with PM and DM as well. 
 
Figure 8. The distribution of the Work Environment Impact Scale (WEIS) in patients with PM or 
DM (n=38).  
PM=Polymyositis, DM=Dermatomyositis, n=number, %=percentage. 
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A lower self-rated work ability, according to the WAI, correlated well to a lower percentage 
of full-time employment (rs 0.8, p<0.01 (Figure 9) (Paper IV). Accordingly, a large 
proportion of the patients (n=27) had a need to restore or improve their work ability (Paper 
IV) (Figure 9). 
 
 
 
Figure 9. Percentage of full-time employment in relation to self-rated work ability (total WAI score) 
n=48.  
n=number, rs= Spearman correlation coefficient, p=probability value. 
rs0.81; p<0.01  
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The self-rated work ability additionally correlated to the following work-related risk factors: 
more frequent occurrence of work with arm/hand stretched forward (rs 0.79, p<0.001), 
forceful movements and uncomfortable hand positions/grips (rs 0.43, p=0.003) and back 
bent forward, backwards, sideways, or/and twisted repeatedly or for long periods of time 
(rs 0.48, p=0.001) (Paper IV).  
Moderate to high positive correlations were seen between self-rated work ability and five 
items of the WEIS (Paper IV). For example, a lower self-rated work ability (total WAI 
score) was associated with having tasks that were too demanding to handle (Task 
Demand; rs 0.7, p<0.01), not having enough time to manage the workload (Time Demand; 
rs 0.5, p<0.01), not having enough challenges in their work (Appeal to Work Task; rs 0.5, 
p<0.05), excessive expectations on work performance (Work Role Standard; rs 0.5, 
p<0.01), and not having the opportunity to influence working hours (Work Schedule; rs 
0.4, p<0.05) (Paper IV). These results emphasise the importance of the physical and 
psycho-social work environment for the self-rated work ability (Paper IV). In the future, a 
study with a qualitative approach would enhance the understanding of the factors that led 
to permanent sick leave. 
4.3 Health-related quality of life in patients with PM and 
DM (Papers I and II) 
Next we wanted to investigate how the disease affects HRQoL and how HRQoL 
correlates to the reduced grip force.  
In Paper I, the patients with PM and DM rated the HRQoL lower in all dimensions of SF-
36 compared to the general population in Sweden from the literature (Paper I) (120). 
Health-related quality of life measure used in this thesis was linked to the ICF 
components of body function, and activities and participation. 
In the general population, there is a gender difference where the men rate their HRQoL 
better than the women (82). However, this difference was not detected in our study 
(Paper I) (120). In Paper II, we wanted to further investigate whether the lower ratings of 
HRQoL were present at different time-points. In that study (Paper II), we found that the 
HRQoL was rated lower in both women and men with PM and DM compared to the 
general population at the time of diagnosis (Paper II).  
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The women with PM and DM also had lower values at disease duration 1, 2, 3, and 6 
years, while the men reported lower HRQoL only after 2 years disease duration (Paper II). 
The dimensions of General Health and Vitality were more commonly rated lower in 
women with PM and DM compared to the general population (Paper II), suggesting that 
women with PM and DM perceive the disease differently from men or are more affected 
by the disease than the men with PM and DM. This could, however, not have been 
answered by the study design used in this study (Paper II). It would also have been 
interesting to explore how the HRQoL changed over time in patients with PM and DM and 
if it changed differently between women and men. However, the HRQoL data in Paper II 
did not permit an analysis over time. Other studies have described the negative effect of 
myositis disease on a patient’s HRQoL (4, 75). Also, it is well known that the disease 
negatively affects the HRQoL when other rheumatic conditions are present (133).  
Quality of life is of importance for patients’ health and is therefore central to address in 
clinical practice. Since HRQoL in patients with PM and DM is affected at the time of 
diagnosis, it is important to confront this issue at the beginning of the care. In rheumatic 
diseases, there are factors that promote HRQoL, such as having a strong sense of 
coherence, feeling rested after sleep, and having work capacity (134). It has yet to be 
explored whether these factors would be promoting for patients with PM and DM. 
Promoting factors could be the base of an intervention to increase HRQoL in patients with 
PM and DM.  
The HRQoL dimension Vitality and Mental Health (SF-36) in women with PM and DM was 
associated with the grip force (Paper I) (120). In Paper II, we found that impaired grip 
force in patients with PM and DM had associations as well to the dimensions Role 
Physical, Mental Health, and General Health (SF-36) up to 4 years. Although these 
correlations were present only at one time point each in Paper II, this observation is in 
agreement with the results in Paper I (120). Interestingly, grip force has been found to 
predict poorer general health (87) and mortality, especially in those with reported disease 
compared to those who were healthy in a general population of elderly participants  
(86, 87). One possible explanation could be that with poorer health, the activities 
performed during a day may be less than usual due to the health condition; the reduced 
use of the hands could be a consequence, leading to a lower grip force.  
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Despite conventional treatment, patients with PM and DM have reduced grip force, and it 
seems to affect both activity and HRQoL, which might indicate a need for targeted 
therapies, such as hand exercises. 
4.4 Hand exercise as an intervention (Paper III) 
As a result of the observed low grip force despite pharmacological treatment (Papers I 
and II), we found it of clinical importance to develop an intervention with a focus to 
improve hand function and additionally have an effect (improve or maintain) on activity 
performance (120, 122). Therefore, we developed a hand exercise programme to test its 
feasibility and the preliminary results of its effect on hand function and activity. The results 
in Paper III showed that the hand exercise programme was feasible but had a limited 
effect on hand function and activity performance (122). The measures used to evaluate 
hand function and activity limitation in Paper III have links to the ICF components body 
function, and activities and participation 
We could demonstrate that patients with PM and DM had good adherence (> 75%) in 
completing a hand exercise programme (122). Feasibility, adherence, and relevant 
outcome measures are of importance when designing a new therapeutic intervention. 
Aspects that are known to positively influence adherence are supervision, the use of an 
exercise diary, the number of movements prescribed, and if the patient perceives the 
intervention as beneficial (135-138).  
The hand exercise intervention in Paper III was primarily home-based with an average of 
four follow-ups conducted either by phone or at the hospital (122). As recommended, all 
participating patients filled in the exercise diary. A low number (≤3) of movements predict 
good adherence in patients with neck and low-back pain (138). The number of 
movements in our study was between six and eight, but this did not seem to influence 
adherence (122) (Table 8).  
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At baseline, all patients had reduced hand grip strength by approximately 32% in the right 
hand and 30% in the left hand, but whether this reduced handgrip strength was perceived 
as reduced or if it affected the patients’ ability to perform daily activities was not 
addressed in the current study (Paper III) (122).  
However, in other rheumatic diseases, reduced hand grip strength has been shown to be 
associated with activity limitations (125, 139, 140). 
 
 
Table 8. Measures of adherence as a total and based on exercise location and measures of 
exertion at baseline and at different time-points in the hand exercise intervention. 
Patient 
ID 
Adherence 
(0-36) 
PRE Borg CR 10 scale 
(0-10) 
Total 
exercise 
sessions 
n 
Exercise 
sessions at 
the hospital 
n 
Exercise 
sessions 
at home 
n 
Baseline 
 
Week 1-4 
median 
(IQR) 
Week 5-8 
median 
(IQR) 
Week 9-
12 
median 
(IQR) 
1 31 0 31 5 5 (4.8-5.3) 5 (4-5) 5 (4.3-5.8) 
2 36 0 36 5 3 (3-3) 3 (3-3) 3 (3-3) 
3a 33 1 32 8 6 (6-7) 6 (6-6) 6 (6-6) 
4 34 1 33 7 5 (4-5) 5 (4-7) 4 (4-5) 
5 34 5 29 7 3 (3-3) 3 (2.8-4) 3 (2-3) 
6 30 7 23 5 4 (3-4) 1 (0-1.3) 0 (0-0.5) 
7 28 1 27 3 No reported measures 
8 36 5 31 4 3 (3-4) 4 (3.3-4) 3 (3-4) 
9 36 3 33 3 2.5 (2-3) 4 (3.3-4) 4 (4-4) 
10a 35 1 34 7 3 (2-5.5) 2 (2-3) 3 (2-3.8) 
11 31 1 30 3 3 (2.3-4) 4 (3-4) 4 (3-4) 
n=number, RPE= Rating of Perceived Exertion, CR= Category Ratio, IQR= Interquartile Range,  
a = left hand dominance 
 
 
The patients rated their exertion on a moderate level (3 or 4) on the PRE Borg CR 10 
scale throughout the 12-week intervention (122) (Table 8). There are recommendations to 
have this level of exertion as an initial load and then increase the load to strong exertion 
(5 or 6) (41). These results indicate that there would be a possibility to increase the 
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resistance in the hand exercise programme. The patients thought that 30 repetitions were 
too many and took too long to perform (122). With a more appropriate hand training 
dough that has a higher initial resistance, the number of repetitions could be reduced 
since there are new exercise dough types that have recommendations based on hand 
strength.  
We demonstrated that patients with PM and DM can improve in hand function and activity 
performance using a hand exercise programme (122). However, improvement was limited 
using the current exercise regimen, indicating a need to modify the programme. The hand 
exercise programme consisted of different movements to strengthen the muscles of the 
hand. The movements were done with up to 30 repetitions, which indicate that the 
programme might improve muscular endurance. Another reason for the limited result 
might be that the assessment used to evaluate muscle endurance (Jamar and pinch grip 
strength) measures peak strength. This may indicate that the programme trained one 
aspect (endurance), and the measures assessed another (peak strength). However, in 
other rheumatic and muscle-affecting diseases, hand exercise is commonly used as a 
treatment in occupational therapy; studies on hand exercise have shown improvements in 
hand function (51, 52, 54, 141). 
Patients with PM and DM did not have reduced grip ability as measured by GAT (Paper 
III) (122). The reason for this finding could be that patients with PM and DM have good 
grip ability or that this measure did not include grips that may be impaired in patients with 
PM and DM since the GAT was developed for patients with arthritis (99). In both 
rheumatoid arthritis and systemic sclerosis, reduced joint mobility and impaired grip ability 
are present (139, 142-144). The results from Paper I showed only small limitations in joint 
mobility (120). 
Therefore, a hand exercise programme focusing on increasing grip strength, dexterity, 
and activity performance with increased resistance in the movements and limiting the 
duration of each exercise session would be preferable in a future study. 
4.5 Methodological discussion 
The results from this thesis will add to the knowledgebase on hand function, activity, and 
participation in patients with PM and DM. To describe the methods and results in the 
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thesis, the ICF level-one classification was used. The use of a level-one classification 
gives a broad description about what ICF components and categories in the ICF might be 
impaired in patients with PM and DM. Further studies would be of interest to enable 
disease-specific core sets for patients with myositis. 
A general limitation of the studies in Papers I-III is that the measures of grip force, grip 
strength, and HRQoL were compared to reference values from the literature. There is a 
limitation of using literature-derived control groups. To handle this, a gender- and age-
matched value was collected from the literature for every patient.  
In Paper I, the mean value for this control group was used in the one-sample t-test 
analysis. In Papers II and III, to address the deficiency of a control group, the analyses 
were more appropriately done by standardizing the observed values (mean values and 
standard deviations) and testing the null hypothesis (=there are no differences) by using 
the Wilcoxon Signed-rank test. Even though there was the limitation of using normative 
values from the literature, the comparable values along with patient-reported 
assessments provided a direction of whether the patients had disabilities or not.  
The E-link pinch meter has a thinner profile than the regular pinch gauge meter and could 
therefore not be compared to normative values. In the future, a study to derive normative 
values for the E-link pinch meter would give valuable information about the pinch grip 
strength. 
The measures of activity and participation (MAP, DASH) used in this thesis enabled a 
description of what limitations and restrictions are present in patients with PM and DM 
(89, 90, 104). However, these measures did not evaluate if the activity is meaningful 
(occupation), whether the participants actually perform it, or if it negatively affects their 
lives (61, 63, 64). Only a few articles have assessed activity limitation in patients with PM 
and DM (2, 33, 39, 145). Therefore, the results from this thesis will add to the 
knowledgebase of activity and participation in patients with PM and DM. 
One previous study showed that the MAP covers some of the activities that are important 
to improve for patients with PM and DM (146). However, some areas are still missing in 
the MAP, such as sexual activity, sleep, and bicycling (146). In the future, it would be of 
interest to investigate which activities limit patients and which are of importance.  
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A patient-derived activity limitation measure would be preferred both in research and in 
clinical practice. 
In this thesis, the SF-36 was chosen to evaluate HRQoL. As with the MAP and DASH 
measures, there might be areas of HRQoL that are important to the patient but are not 
covered by the SF-36. Therefore, it is necessary to perform qualitative studies to explore 
areas where the patients need support so that the health care providers can help the 
patients in the most appropriate way.  
The WAI was able to detect reduced work ability in patients with PM and DM. The WAI 
has been used to predict the use of health care and rehabilitation and has also been 
shown to have associations to HRQoL (147), suggesting the use of WAI as a screening 
tool to evaluate self-rated work ability in patients with PM and DM in clinical practice. 
In Paper II, the SweMyoNet Registry was used to collect data on grip force and HRQoL 
over time from the time of diagnosis. Missing data in registries based on data collected 
through clinical practise are a known general limitation of registries. Other explanations 
for the missing values may include the medical condition of the patient or potentially 
missed values from patients with the most severe or mild disability. To handle missing 
values and small sample sizes in the analysis, the Bonferroni after test was used to 
modify significance levels. The mixed linear model was used to enable an analysis over 
time despite the missing values (117). Still, we cannot exclude that the missing values 
may have affected the results in either a or negative manner. Furthermore, the lower 
number of observations after two years makes data from the later time points less 
reliable, particularly when subgrouping in women and men.  
The aim of Paper III was to develop a hand exercise programme and to primarily test its 
feasibility in patients with PM and DM. Even though information about its effect on hand 
function and activity performance would have been beneficial for clinical practice 
guidelines, these results were not to be expected with this small convenience sample. 
However the study did give directions on how to improve the programme design and what 
measures to include in a future study. A limitation in Paper III was that at the time when 
the hand exercise study was initiated there were no guidelines on which resistance putty 
to use based on hand grip strength which nowadays are available. This resulted in a more 
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subjective estimation of the resistance in the dough and for the participants a too time-
consuming programme.  
Paper IV included patients both working and on sick leave for more than two years, 
enabling a possible comprehensive picture about work ability in patients with PM and DM. 
However, there might be a recall bias since the patients that had been on sick leave for 
more than 2 years had a range up to 162 months (≈14 years) of sick leave. 
4.6 Summary 
This thesis has used outcome measures that in some cases have links to the ICF 
components of body function and structures, activities and participation, and 
environmental and personal factors. The DASH and SF-36 are represented in several of 
the ICF components (84, 106). Regarding disabilities in body functions, the major results 
from these studies were reduced grip force and hand grip strength in patients with PM 
and DM (Figure 10). The impairment was present at different time points and had 
associations to both activities and HRQoL (Papers I, II, and III) (120, 122).  
In the components of activities and participation, patients with PM and DM perceived the 
activities of moving around, work, and leisure as most limiting. Health-related quality of life 
was rated low and was linked to both body functions and activities and participation. 
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Figure 10. A summary of the results appears in this thesis and the results of disabilities in patients 
with PM and DM are linked to these ICF components.  
a=Health-Related Quality of Life dimensions measured by the SF-36, b=DASH has also been 
linked to personal factors. 
 
 
  
 56 
4.7 Concluding remarks 
In conclusion, I have in this thesis shown that grip force may be affected in patients with 
PM and DM at different time-points from the time of diagnosis. In men with PM and DM 
the reduced grip force was more commonly present within the first one or two years 
after the myositis diagnosis. The reduced grip force could have an impact on activity 
performance and HRQoL. Therefore, it is important to use this new knowledge and refer 
the patients to specific hand therapy and occupational therapists, and to measure the 
grip force in patients with PM or DM as well as to assist patients with assistive devices 
or ergonomic advice when needed. A hand exercise programme seems to be feasible 
to use in patients with PM and DM, but the design of the programme needs to be further 
evaluated to offer improvements in hand function and activity performance.  
Furthermore, work was rated as one of the most difficult activities in patients with PM 
and DM. In these patients, poor self-rated work ability was common, and there were 
interfering factors in the work environment that may be related to disease-specific 
impairment of muscle performance that affect the work performance and indicate a 
need to identify these interfering factors and to support the patients when required to 
enhance their work performance. 
There is also a need to increase the national and international cooperation regarding 
research in this rather rare disease. Quality registers are important for research and 
ultimately for the care and treatment of patients with myositis. It is also important to 
include the patient in the study design so that the research questions that are being 
asked and hopefully answered consider the patients’ perspective. 
4.8 Clinical implications 
The results from this thesis have added knowledge about hand function, activity limitation, 
work ability and HRQoL in patients with PM and DM. The following suggestions are based 
on the results in this thesis and the author’s opinion: 
 The hand grip strength or grip force are important to evaluate in the clinical care 
of patients with PM and DM. Both the Jamar and the Grippit© seem to be able to 
detect impairments in this body function. I suggest that the grip force or hand grip 
strength is assessed at the time of diagnosis and at the yearly follow-up visits to 
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enable appropriate care and for further research on the impact of hand grip 
strength or grip force in patients with PM and DM. 
 If the hand grip strength or grip force is reduced, patients should be referred to 
specific hand therapy and occupational therapy for ergonomic advice or assistive 
devices to reduce the disability and maintain independence in activity 
performance. 
 The results from this thesis did not give a conclusive answer on how to perform a 
hand exercise intervention in patients with PM and DM. It did, however, indicate 
that a hand exercise intervention is feasible to perform and did not increase the 
disease activity in patients with PM and DM. A hand exercise programme should 
be led by a hand therapist or occupational therapist who has experience with this 
rare disease. The hand exercise should aim to maintain or increase hand 
function and ultimately improve activity performance and HRQoL if possible. 
 There is a need to include a self-reported assessment on work ability in addition 
to the percentage of full-time employment, such as the WAI, in patients with PM 
and DM. My suggestion is to add this measure both in clinical practice and at the 
yearly follow-ups. If added to the SweMyoNet Registry, it would enable a 
longitudinal aspect of work ability and the ability to identify possible sub-group 
characteristics of patients who are more at risk for sick leave and therefore in 
greater need of rehabilitation. 
 The disease-specific symptoms in myositis seemed to affect the ability to remain 
at work, and there was a large proportion of patients with poor or less good self-
rated work ability who still worked. The occupational therapist would be able to 
do jobsite analysis of work demands to adapt the work tasks or the work 
environment to increase work ability. There are assessments that would be 
applicable to use, e.g. the Assessment of Work Performance (AWP) and the 
Assessment of Work Characteristics (AWC) (148). 
 Interaction with co-workers and others was seen as a support to remain at work 
for patients with PM and DM and could be a possible promoting factor to stay at 
work.  
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4.9 Future studies 
As in all research, these results bring out new questions to address: 
 The hand exercise intervention assessed in Paper III seemed to be feasible with 
good adherence but with limited effect on hand function and activity performance. 
To further explore the effect of a hand exercise programme in patients with PM 
and DM, a repeated-measure design, single case methodology or statistical 
process control should be undertaken (149). The hand exercise programme 
should have limited movements with a higher initial resistance. In addition, it 
would also be interesting to investigate whether a hand exercise programme may 
have a positive effect on HRQoL. 
 The dexterity was reduced in a small convenience sample of patients with PM 
and DM. This aspect of hand ability needs to be addressed in a larger cohort, 
preferably with patients with PM and DM that have and have not experienced 
reduced hand grip strength. Adding the measure of dexterity in the SweMyoNet 
Registry would enable this kind of study. 
 The results indicate the importance of evaluating the work ability in patients with 
PM and DM. Future studies should aim to investigate different patient 
characteristics that are risk factors for sick leave in myositis. This type of study 
would be possible if a measure of self-rated work ability were added to the 
SweMyoNet Registry.  
 It would also be interesting to investigate, using qualitative methodology, what the 
facilitators or barriers are for remaining at work or not. 
 In the future, a study investigating the effects of work-related interventions such 
as the use of adaptation, assistive technology or work place redesign would be 
interesting.  
 In qualitative studies, activity limitation and HRQoL should be explored in PM and 
DM patients to investigate the extent to which hand function affects activity and 
HRQoL. 
  59 
5 Acknowledgements 
First of all, I would like to give my warmest gratitude to all the patients with polymyositis 
and dermatomyositis that have so willingly shared valuable information about their 
perception of their disease. I would like to thank the Research School of Caring Sciences, 
and the Department of Neurobiology, Care Sciences and Society, past and present head 
of division of nursing for making this thesis and doctoral education possible. 
I would like to thank those who also have funded this thesis: the Swedish Research 
Council; the Swedish Rheumatism Association; King Gustaf V 80-Year Foundation; 
Funds at the Karolinska Institutet; and through the regional agreement on medical training 
and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. 
I would like to thank all my supervisors for their support during my journey. You have all 
contributed in your own special way. Elisabet, my main supervisor, you have always 
encouraged me with your metaphors like “quicksand manuscript” or “stone tablets from 
God”. You are sensitive to my feelings and have always made me feel like I am important, 
even though your own schedule has been full with other obligations. Thank you for taking 
me on for this journey. 
Ingrid, without you, this thesis would not have been written. When I was new in the 
myositis team and had just started my master’s project, you encouraged me to write 
about hand function in myositis. That essay became Paper I in this thesis. If you believe 
that I can do it, than (I guess) I better believe it too. 
Marie-Louise, when we were writing the application to the research school, Ingrid and 
Elisabeth wondered if I knew an occupational therapist that I would like to consider as a 
supervisor. My first choice was, of course, you, and I am so glad that you accepted the 
assignment! During our meetings at Danderyd, you helped me to focus and find 
perspective. I left with a feeling of flying due to the boost of energy and optimism. Thank 
you. 
To Anna Aldehag my mentor and role-model, thank you so very much for being there for 
me. You have always been so positive and giving me advice when I needed it the most.  
I hope we can continue our lunch dates in the future. 
 60 
To my co-authors Jan Sandqvist, Maryam Dastmalchi, Lara Dani, Maria Lidén, Kerstin 
Lundsten Helene Alexanderson, Li Alemo Munters, Anna Aldehag and Yvonne Axelsson 
thank you for your collaboration. 
To my roommates Susanne Pettersson and Li Alemo Munters, I am the last one to go. 
You have both been good friends with whom to discuss both work-related and personal 
issues with great delight. Susanne, we have a common obsession of doing tables and 
figures the best possible way, and please do not let me go in to SPSS syntax. Thank you 
for being there! Li, my superwoman, what will I do without you? I have very much 
appreciated our run-talks in Hagaparken. Thank you for all the laughs and your insightful 
discussions. 
I would like to thank the present and past myositis research group for all the good 
discussions and the open climate that makes all of us flourish and become the best we 
possibly could. Helene Alexanderson you have been there from the start giving support 
and advice along the way, thank you. I am looking forward to our continued collaboration. 
Anna Tjärnlund, you are a sharp woman, always saying the right thing and being so 
perceptive. I will always have the warmest memories when thinking about our trip to Los 
Angeles. 
Thank you Christina Ottosson for our nice talks in your office and your help in organising 
my study projects. Maryam Dastmalchi thank you for inviting us to your home, your 
support and you invaluable help with data collection and manuscript writing. I would also 
like to thank Per-Johan Jakobsson, Louise Ekholm, Karina Gheorghe, Catarina Forsberg 
and Helena Hellström for helping me collecting data for my studies. 
Thanks to all former and present members of Vårdforskargruppen Reuma. Special thanks 
to Joanna Tingström Eva Waldheim and Helena Lööf. 
Thank you Louise Nygård and Lena Borell for letting me join the kreativa konditoriet. 
I would like to direct my warmest thanks to the Occupational Therapy Department at 
Karolinska University Hospital for support and encouragement during my leave of 
absence. To present and past reumagruppen Carin Renger, Katarina Nordh, Åsa 
Lindberg, Karin Åström, Linnea Bastrup Frank, Helena Wikholm, Johanna Ellung, Malin 
Frohm, Anna-Karin Ekström, Sofia Borg, Daniela Sarkan, Eva Jönsson, thanks a million! 
  61 
Yvonne Axelsson, thank you for your invaluable help with collecting data but most 
importantly your wise advice and pep talks. 
I would also like to thank the Department of Rheumatology, Karolinska University 
Hospital, for letting me participate in the inspiring environment. 
To my classmates from the Research School of Caring Sciences, I very much 
appreciated you being there when I was a new Ph.D. student! I hope we will get to work 
together again on the other side of dissertation….. 
I would also like to thank Gertie Johansson at the Hagströmmer library for helping me with 
the cover picture. To Susanne Karlfeldt, Gunnel Bemerfeldt, Stina Nordman, Maria Klein, 
Yvonne Edlund, Annica Karlsson, Annette Karlsson, Carina Dahlin Alfred Nyeko, Pia 
Johansson, Susanna Farkas and Inga Lodin thank you for all your help. 
To my friends Charlotte, Mie, Anna who have put up with my endless talk about work, 
thank you. 
Mamma, Pappa och Mona, Monica och Ida, Puss Gittan och Lasse, Mormor och Farmor 
(mitt största fan) tack så mycket för att ni fanns där för mig och att ni är Mina nära och 
kära. Åsa, Bertil, Isabella och Calle tack för allt ert stöd och all er hjälp i vardagen. 
Min familj ni är min bas och min fasta punkt. Ni hjälper mig att fokusera på det som är 
viktigt. Min egen Agent P och Mina Jakob tack för att ni inte låter mig fastna vid datorn 
utan lockar mig med lekar som ”mamma pappa barn”, ”leka bilar” eller disco! Olle min 
älskade man. Vi har gjort denna resa tillsammans och du har alltid ställt upp för mig och 
prioriterat mina behov, jag är så oerhört tacksam. Jag lovar att nu är det din tur!  
Jag älskar dig så oerhört mycket.  
 62 
6 References 
1. Socialstyrelsen WHO. Klassifikation av funktionstillstånd, funktionshinder och hälsa: 
svensk version av International classification of functioning, disability and helath (ICF). 
Kortversion ed. Stockholm: Socialstyrelsen; 2003. 151 p. 
2. Hicks JE. Role of rehabilitation in the management of myopathies. Current opinion in 
rheumatology. 1998;10(6):548-55. Epub 1998/11/13. 
3. Bronner IM, van der Meulen MF, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE, 
et al. Long-term outcome in polymyositis and dermatomyositis. Annals of the rheumatic 
diseases. 2006;65(11):1456-61. Epub 2006/04/12. 
4. Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Danko K. Functional outcome 
and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology. 
2005;44(1):83-8. Epub 2004/09/24. 
5. Furst DE, Amato AA, Iorga SR, Gajria K, Fernandes AW. Epidemiology of adult 
idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle & nerve. 
2012;45(5):676-83. Epub 2012/04/14. 
6. Ahlstrom G, Gunnarsson LG, Leissner P, Sjoden PO. Epidemiology of neuromuscular 
diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology. 
1993;12(5):262-9. Epub 1993/01/01. 
7. Dalakas MC. Review: An update on inflammatory and autoimmune myopathies. 
Neuropathology and applied neurobiology. 2011;37(3):226-42. Epub 2010/12/16. 
8. Zhang L, Wang GC, Ma L, Zu N. Cardiac involvement in adult polymyositis or 
dermatomyositis: a systematic review. Clinical cardiology. 2012;35(11):686-91. Epub 
2012/08/01. 
9. Marie I. Therapy of polymyositis and dermatomyositis. Presse Med. 2011;40(4 Pt 
2):e257-70. Epub 2011/02/22. 
10. Loell I, Lundberg IE. Can muscle regeneration fail in chronic inflammation: a 
weakness in inflammatory myopathies? Journal of internal medicine. 2011;269(3):243-57. 
Epub 2011/01/06. 
11. Hengstman GJ, van den Hoogen FH, van Engelen BG. Treatment of the inflammatory 
myopathies: update and practical recommendations. Expert opinion on pharmacotherapy. 
2009;10(7):1183-90. Epub 2009/05/02. 
  63 
12. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). The New 
England journal of medicine. 1975;292(7):344-7. Epub 1975/02/13. 
13. Marie I, Mouthon L. Therapy of polymyositis and dermatomyositis. Autoimmunity 
reviews. 2011;11(1):6-13. Epub 2011/07/12. 
14. Alexanderson H. Exercise in inflammatory myopathies, including inclusion body 
myositis. Current rheumatology reports. 2012;14(3):244-51. 
15. Alexanderson H, Lundberg IE. Exercise as a therapeutic modality in patients with 
idiopathic inflammatory myopathies. Current opinion in rheumatology. 2012;24(2):201-7. 
Epub 2011/12/23. 
16. Alemo Munters L, Dastmalchi M, Katz A, Esbjornsson M, Loell I, Hanna B, et al. 
Improved exercise performance and increased aerobic capacity after endurance training 
of patients with stable polymyositis and dermatomyositis. Arthritis research & therapy. 
2013;15(4):R83. Epub 2013/08/15. 
17. Nader GA, Lundberg IE. Exercise as an anti-inflammatory intervention to combat 
inflammatory diseases of muscle. Current opinion in rheumatology. 2009;21(6):599-603. 
18. Alemo Munters L, Dastmalchi M, Andgren V, Emilson C, Bergegard J, Regardt M, et 
al. Improvement in health and possible reduction in disease activity using endurance 
exercise in patients with established polymyositis and dermatomyositis: a multicenter 
randomized controlled trial with a 1-year open extension followup. Arthritis care & 
research. 2013;65(12):1959-68. Epub 2013/07/19. 
19. World Health Organization. International classification of functioning, disability and 
health : ICF. Geneva: World Health Organization; 2001. iii, 299 p. p. 
20. Ustun TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The International 
Classification of Functioning, Disability and Health: a new tool for understanding disability 
and health. Disability and rehabilitation. 2003;25(11-12):565-71. Epub 2003/09/10. 
21. WHO. International classification of functioning, disability and health. Geneva: World 
Health Organization2008. 373 p. 
22. SFS 1982:763 The Swedish Helath and Medical services act [HSL] (Hälso 
sjukvårdslagen ), (1982). 
23. Cieza A, Ewert T, Ustun TB, Chatterji S, Kostanjsek N, Stucki G. Development of ICF 
Core Sets for patients with chronic conditions. Journal of rehabilitation medicine : official 
journal of the UEMS European Board of Physical and Rehabilitation Medicine. 2004(44 
Suppl):9-11. Epub 2004/09/17. 
 64 
24. Schwarzkopf SR, Ewert T, Dreinhofer KE, Cieza A, Stucki G. Towards an ICF Core 
Set for chronic musculoskeletal conditions: commonalities across ICF Core Sets for 
osteoarthritis, rheumatoid arthritis, osteoporosis, low back pain and chronic widespread 
pain. Clinical rheumatology. 2008;27(11):1355-61. Epub 2008/06/04. 
25. Uhlig T, Moe R, Reinsberg S, Kvien TK, Cieza A, Stucki G. Responsiveness of the 
International Classification of Functioning, Disability and Health (ICF) Core Set for 
rheumatoid arthritis. Annals of the rheumatic diseases. 2009;68(6):879-84. Epub 
2008/07/16. 
26. Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, et al. ICF Core Sets for 
rheumatoid arthritis. Journal of rehabilitation medicine : official journal of the UEMS 
European Board of Physical and Rehabilitation Medicine. 2004(44 Suppl):87-93. Epub 
2004/09/17. 
27. Rauch A, Kirchberger I, Boldt C, Cieza A, Stucki G. Does the Comprehensive 
International Classification of Functioning, Disability and Health (ICF) Core Set for 
rheumatoid arthritis capture nursing practice? A Delphi survey. International journal of 
nursing studies. 2009;46(10):1320-34. Epub 2009/05/22. 
28. Kirchberger I, Glaessel A, Stucki G, Cieza A. Validation of the comprehensive 
international classification of functioning, disability and health core set for rheumatoid 
arthritis: the perspective of physical therapists. Physical therapy. 2007;87(4):368-84. Epub 
2007/02/22. 
29. Kirchberger I, Stamm T, Cieza A, Stucki G. Does the Comprehensive ICF Core Set 
for rheumatoid arthritis capture occupational therapy practice? A content-validity study. 
Canadian journal of occupational therapy Revue canadienne d'ergotherapie. 2007;74 
Spec No.:267-80. Epub 2007/09/12. 
30. Coenen M, Cieza A, Stamm TA, Amann E, Kollerits B, Stucki G. Validation of the 
International Classification of Functioning, Disability and Health (ICF) Core Set for 
rheumatoid arthritis from the patient perspective using focus groups. Arthritis research & 
therapy. 2006;8(4):R84. Epub 2006/05/11. 
31. Stamm TA, Cieza A, Coenen M, Machold KP, Nell VP, Smolen JS, et al. Validating 
the International Classification of Functioning, Disability and Health Comprehensive Core 
Set for Rheumatoid Arthritis from the patient perspective: a qualitative study. Arthritis and 
rheumatism. 2005;53(3):431-9. Epub 2005/06/04. 
32. Stamm TA, Mattsson M, Mihai C, Stocker J, Binder A, Bauernfeind B, et al. Concepts 
of functioning and health important to people with systemic sclerosis: a qualitative study in 
four European countries. Annals of the rheumatic diseases. 2011;70(6):1074-9. Epub 
2011/05/05. 
  65 
33. Harris-Love MO. Physical activity and disablement in the idiopathic inflammatory 
myopathies. Current opinion in rheumatology. 2003;15(6):679-90. Epub 2003/10/22. 
34. Lachenbruch PA, Miller FW, Rider LG. Developing international consensus on 
measures of improvement for patients with myositis. Statistical methods in medical 
research. 2007;16(1):51-64. Epub 2007/03/07. 
35. Helene Alexanderson, Maria Del Grande, Clifton O.  Bingham III, Ana-Maria Orbai, 
Catherine Sarver, Katherine Clegg-Smith, et al. Patient -reported outcomes and adult 
patients’ disease experience in the idiopathic inflammatory myopathies. A Report from the 
OMERACT 11 Myositis Special Interest Group. The Journal of rheumatology. 2014. 
36. Flinn NA, Trombly Latham CA, Robinson Podolski C. Assessing abilities and 
capacities:range of motion, strength and endurance. In: Radomski MV, Trombly Latham 
CA, editors. Occupational Therapy for physical dysfunction. 6th ed. China: Lippincott 
Williams& Wilkins, a Wolters Kulwer business; 2008. 
37. Prosser R, Conolly WB. Rehabilitation of the hand and upper limb. Edinburgh: 
Butterworth-Heinemann; 2003. viii, 379 s. p. 
38. Ponyi A, Constantin T, Garami M, Andras C, Tallai B, Vancsa A, et al. Cancer-
associated myositis: clinical features and prognostic signs. Annals of the New York 
Academy of Sciences. 2005;1051:64-71. Epub 2005/08/30. 
39. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J 
Med. 1991;325(21):1487-98. Epub 1991/11/21. 
40. Klein M, Mann H, Hánová P, Pleštilová L, Závada J, Remáková M, et al. Arthritis in 
patients with idiopathic inflammatory myopathies (A10.3). Annals of the rheumatic 
diseases, the EULAR journal. 2013;72(Suppl 1). 
41. Heine PJ, Williams MA, Williamson E, Bridle C, Adams J, O'Brien A, et al. 
Development and delivery of an exercise intervention for rheumatoid arthritis: 
strengthening and stretching for rheumatoid arthritis of the hand (SARAH) trial. 
Physiotherapy. 2012;98(2):121-30. 
42. Waljee JF, Chung KC, Kim HM, Burns PB, Burke FD, Wilgis EF, et al. Validity and 
responsiveness of the Michigan Hand Questionnaire in patients with rheumatoid arthritis: 
a multicenter, international study. Arthritis care & research. 2010;62(11):1569-77. Epub 
2010/06/04. 
43. den Ouden ME, Schuurmans MJ, Mueller-Schotte S, Brand JS, van der Schouw YT. 
Domains contributing to disability in activities of daily living. Journal of the American 
Medical Directors Association. 2013;14(1):18-24. Epub 2012/10/10. 
 66 
44. Chung KC, Burns PB, Reichert HA, Fox DA, Burke FD, Wilgis EF, et al. Properties of 
the International Classification for Functioning, Disability and Health in assessing hand 
outcomes in patients with rheumatoid arthritis. Journal of rehabilitation medicine : official 
journal of the UEMS European Board of Physical and Rehabilitation Medicine. 
2011;43(4):292-8. Epub 2011/01/27. 
45. Kjeken I, Dagfinrud H, Slatkowsky-Christensen B, Mowinckel P, Uhlig T, Kvien TK, et 
al. Activity limitations and participation restrictions in women with hand osteoarthritis: 
patients' descriptions and associations between dimensions of functioning. Annals of the 
rheumatic diseases. 2005;64(11):1633-8. Epub 2005/04/15. 
46. Metcalf C, Adams J, Burridge J, Yule V, Chappell P. A review of clinical upper limb 
assessments within the framework of the WHO ICF. Musculoskeletal care. 2007;5(3):160-
73. Epub 2007/07/05. 
47. Nordenskiold UM, Grimby G. Grip force in patients with rheumatoid arthritis and 
fibromyalgia and in healthy subjects. A study with the Grippit instrument. Scandinavian 
journal of rheumatology. 1993;22(1):14-9. Epub 1993/01/01. 
48. Massy-Westropp N, Rankin W, Ahern M, Krishnan J, Hearn TC. Measuring grip 
strength in normal adults: reference ranges and a comparison of electronic and hydraulic 
instruments. The Journal of hand surgery. 2004;29(3):514-9. Epub 2004/05/14. 
49. Steultjens EM, Dekker J, Bouter LM, van Schaardenburg D, van Kuyk MA, van den 
Ende CH. Occupational therapy for rheumatoid arthritis: a systematic review. Arthritis and 
rheumatism. 2002;47(6):672-85. 
50. Buljina AI, Taljanovic MS, Avdic DM, Hunter TB. Physical and exercise therapy for 
treatment of the rheumatoid hand. Arthritis and rheumatism. 2001;45(4):392-7. Epub 
2001/08/15. 
51. Wessel J. The effectiveness of hand exercises for persons with rheumatoid arthritis: a 
systematic review. Journal of hand therapy : official journal of the American Society of 
Hand Therapists. 2004;17(2):174-80. Epub 2004/05/27. 
52. Ronningen A, Kjeken I. Effect of an intensive hand exercise programme in patients 
with rheumatoid arthritis. Scandinavian journal of occupational therapy. 2008;15(3):173-
83. Epub 2009/01/31. 
53. Brorsson S, Hilliges M, Sollerman C, Nilsdotter A. A six-week hand exercise 
programme improves strength and hand function in patients with rheumatoid arthritis. 
Journal of rehabilitation medicine : official journal of the UEMS European Board of 
Physical and Rehabilitation Medicine. 2009;41(5):338-42. Epub 2009/04/14. 
  67 
54. Aldehag A, Jonsson H, Lindblad J, Kottorp A, Ansved T, Kierkegaard M. Effects of 
hand-training in persons with myotonic dystrophy type 1 - a randomised controlled cross-
over pilot study. Disability and rehabilitation. 2013;35(21):1798-807. Epub 2013/03/14. 
55. Rogers MW, Wilder FV. Exercise and hand osteoarthritis symptomatology: a 
controlled crossover trial. Journal of hand therapy : official journal of the American Society 
of Hand Therapists. 2009;22(1):10-7; discussion 9-20; quiz 18. Epub 2008/11/18. 
56. Dziedzic K, Hammond A. Rheumatology : evidence-based practice for 
physiotherapists and occupational therapists. Hammond A, editor. Edinburgh ; New York: 
Churchill Livingstone; 2010b. xv, 362 p. p. 
57. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. 
American College of Sports Medicine position stand. Quantity and quality of exercise for 
developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in 
apparently healthy adults: guidance for prescribing exercise. Medicine and science in 
sports and exercise. 2011;43(7):1334-59. 
58. Rapoliene J, Krisciunas A. The effectiveness of occupational therapy in restoring the 
functional state of hands in rheumatoid arthritis patients. Medicina. 2006;42(10):823-8. 
59. Clarke AE, Bloch DA, Medsger TA, Jr., Oddis CV. A longitudinal study of functional 
disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis and 
rheumatism. 1995;38(9):1218-24. Epub 1995/09/01. 
60. Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al. 
Polymyositis and dermatomyositis: short term and longterm outcome, and predictive 
factors of prognosis. The Journal of rheumatology. 2001;28(10):2230-7. Epub 
2001/10/24. 
61. Nelson DL. Occupation: form and performance. The American journal of occupational 
therapy : official publication of the American Occupational Therapy Association. 
1988;42(10):633-41. Epub 1988/10/01. 
62. Pierce D. Untangling occupation and activity. The American journal of occupational 
therapy : official publication of the American Occupational Therapy Association. 
2001;55(2):138-46. Epub 2002/01/05. 
63. Turner AF, Margret; Johnson, Sybil E. Occupational Therapy and Physical 
Dysfunction: Elsevier Health Sciences; 2002. 
64. Golledge J. Distinguishing between occupation, purposeful activity and activity, part 1: 
Review and explanation. British journal of occupational therapy. 1998;61(3):6. 
 68 
65. Price P, Miner S. Occupation emerges in the process of therapy. The American 
journal of occupational therapy : official publication of the American Occupational Therapy 
Association. 2007;61(4):441-50. Epub 2007/08/10. 
66. Royeen CB. Occupation reconsidered. Occupational therapy international. 
2002;9(2):111-20. Epub 2002/10/11. 
67. Holm L, Göteborgs universitet. Återgång i arbete efter sjukskrivning för 
rörelseorganens sjukdomar och lättare psykisk ohälsa : en systematisk 
kunskapssammanställning om effekter av interventoner, rehabilitering och exponeringar 
på arbetet. Göteborg: University of Gothenburg; 2010. 112 s. p. 
68. de Croon EM, Sluiter JK, Nijssen TF, Dijkmans BA, Lankhorst GJ, Frings-Dresen MH. 
Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. 
Annals of the rheumatic diseases. 2004;63(11):1362-7. Epub 2004/10/14. 
69. Ilmarinen J, Tuomi K, Klockars M. Changes in the work ability of active employees 
over an 11-year period. Scandinavian journal of work, environment & health. 1997;23 
Suppl 1:49-57. Epub 1997/01/01. 
70. Kielhofner G, Lai JS, Olson L, Haglund L, Ekbadh E, Hedlund M. Psychometric 
properties of the work environment impact scale: a cross-cultural study. Work. 
1999;12(1):71-7. Epub 2002/11/21. 
71. Alavinia SM, de Boer AG, van Duivenbooden JC, Frings-Dresen MH, Burdorf A. 
Determinants of work ability and its predictive value for disability. Occup Med (Lond). 
2009;59(1):32-7. Epub 2008/12/17. 
72. Sandqvist JL, Henriksson CM. Work functioning: a conceptual framework. Work. 
2004;23(2):147-57. Epub 2004/10/27. 
73. Eberhardt K, Larsson BM, Nived K, Lindqvist E. Work disability in rheumatoid arthritis-
-development over 15 years and evaluation of predictive factors over time. The Journal of 
rheumatology. 2007;34(3):481-7. Epub 2007/02/15. 
74. Sharif R, Mayes MD, Nicassio PM, Gonzalez EB, Draeger H, McNearney TA, et al. 
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of 
the GENISOS cohort. Seminars in arthritis and rheumatism. 2011;41(1):38-47. Epub 
2011/03/25. 
75. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic 
inflammatory myositis: morbidity and mortality. Rheumatology (Oxford). 2002;41(1):22-6. 
Epub 2002/01/17. 
  69 
76. Grad FP. The Preamble of the Constitution of the World Health Organization. Bulletin 
of the World Health Organization. 2002;80(12):981-4. Epub 2003/02/07. 
77. Nordenfelt L. The concepts of health and illness revisited. Medicine, health care, and 
philosophy. 2007;10(1):5-10. Epub 2006/09/07. 
78. Hundley JL, Carroll CL, Lang W, Snively B, Yosipovitch G, Feldman SR, et al. 
Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. 
Journal of the American Academy of Dermatology. 2006;54(2):217-20. Epub 2006/01/31. 
79. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. 
Conceptual framework and item selection. Medical care. 1992;30(6):473-83. Epub 
1992/06/11. 
80. Sullivan M, Karlsson J, Taft C, Ware J. SF-36 hälsoenkät: svensk manual och 
tolkningsguide [Swedish manual and interpretation guide]. 2nd ed. Göteborg: 
Sahlgrenska sjukhuset: Sektionen för vårdforskning; 2002. 
81. Ware JE, Jr. SF-36 health survey update. Spine. 2000;25(24):3130-9. Epub 
2000/12/22. 
82. Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-
based validity: results from normative population. Journal of clinical epidemiology. 
1998;51(11):1105-13. Epub 1998/11/17. 
83. Mayo NE, Moriello C, Asano M, van der Spuy S, Finch L. The extent to which 
common health-related quality of life indices capture constructs beyond symptoms and 
function. Quality of life research : an international journal of quality of life aspects of 
treatment, care and rehabilitation. 2011;20(5):621-7. Epub 2010/11/26. 
84. Stucki G, Cieza A. The International Classification of Functioning, Disability and 
Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning. Annals of the 
rheumatic diseases. 2004;63 Suppl 2:ii40-ii5. Epub 2004/10/14. 
85. Alexanderson H, Stenstrom CH, Lundberg I. Safety of a home exercise programme in 
patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford). 
1999;38(7):608-11. Epub 1999/08/26. 
86. Gale CR, Martyn CN, Cooper C, Sayer AA. Grip strength, body composition, and 
mortality. International journal of epidemiology. 2007;36(1):228-35. Epub 2006/10/24. 
87. Sayer AA, Syddall HE, Martin HJ, Dennison EM, Roberts HC, Cooper C. Is grip 
strength associated with health-related quality of life? Findings from the Hertfordshire 
Cohort Study. Age and ageing. 2006;35(4):409-15. Epub 2006/05/13. 
 70 
88. Sullivan M, Karlsson J, Ware JE, Jr. The Swedish SF-36 Health Survey--I. Evaluation 
of data quality, scaling assumptions, reliability and construct validity across general 
populations in Sweden. Soc Sci Med. 1995;41(10):1349-58. Epub 1995/11/01. 
89. Dixon D, Johnston M, McQueen M, Court-Brown C. The Disabilities of the Arm, 
Shoulder and Hand Questionnaire (DASH) can measure the impairment, activity 
limitations and participation restriction constructs from the International Classification of 
Functioning, Disability and Health (ICF). BMC musculoskeletal disorders. 2008;9:114. 
Epub 2008/08/22. 
90. Hunsaker FG, Cioffi DA, Amadio PC, Wright JG, Caughlin B. The American academy 
of orthopaedic surgeons outcomes instruments: normative values from the general 
population. The Journal of bone and joint surgery American volume. 2002;84-A(2):208-
15. Epub 2002/02/28. 
91. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. 
American College of Sports Medicine position stand. Quantity and quality of exercise for 
developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in 
apparently healthy adults: guidance for prescribing exercise. Medicine and science in 
sports and exercise. 2011;43(7):1334-59. Epub 2011/06/23. 
92. Borg GA. Psychophysical bases of perceived exertion. Medicine and science in sports 
and exercise. 1982;14(5):377-81. Epub 1982/01/01. 
93. Borg G. Psychophysical scaling with applications in physical work and the perception 
of exertion. Scandinavian journal of work, environment & health. 1990;16 Suppl 1:55-8. 
Epub 1990/01/01. 
94. Alexanderson H, Broman L, Tollback A, Josefson A, Lundberg IE, Stenstrom CH. 
Functional index-2: Validity and reliability of a disease-specific measure of impairment in 
patients with polymyositis and dermatomyositis. Arthritis and rheumatism. 
2006;55(1):114-22. Epub 2006/02/08. 
95. Jerosch-Herold C, Leite JC, Song F. A systematic review of outcomes assessed in 
randomized controlled trials of surgical interventions for carpal tunnel syndrome using the 
International Classification of Functioning, Disability and Health (ICF) as a reference tool. 
BMC musculoskeletal disorders. 2006;7:96. Epub 2006/12/07. 
96. Oltman R, Neises G, Scheible D, Mehrtens G, Gruneberg C. ICF components of 
corresponding outcome measures in flexor tendon rehabilitation - a systematic review. 
BMC musculoskeletal disorders. 2008;9:139. Epub 2008/10/17. 
  71 
97. Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of 
the measurement of grip strength in clinical and epidemiological studies: towards a 
standardised approach. Age and ageing. 2011;40(4):423-9. Epub 2011/06/01. 
98. Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, et al. Defining 
Clinical Improvement in Adult and Juvenile Myositis. The Journal of rheumatology. 
2003;30(3):603-17. Epub 2003/03/01. 
99. Dellhag B, Bjelle A. A Grip Ability Test for use in rheumatology practice. The Journal 
of rheumatology. 1995;22(8):1559-65. Epub 1995/08/01. 
100. Poole JL. Measures of hand function: Arthritis Hand Function Test (AHFT), 
Australian Canadian Osteoarthritis Hand Index (AUSCAN), Cochin Hand Function Scale, 
Functional Index for Hand Osteoarthritis (FIHOA), Grip Ability Test (GAT), Jebsen Hand 
Function Test (JHFT), and Michigan Hand Outcomes Questionnaire (MHQ). Arthritis care 
& research. 2011;63 Suppl 11:S189-99. Epub 2012/05/25. 
101. Buddenberg LA, Davis C. Test-retest reliability of the Purdue Pegboard Test. The 
American journal of occupational therapy : official publication of the American 
Occupational Therapy Association. 2000;54(5):555-8. Epub 2000/09/28. 
102. Aldehag A, Jonsson H, Littorin S, Ansved T. Reliability of hand function testing 
instruments in patients with muscular dystrophies. International Journal of Therapy and 
Rehabilitation. 2008;15(5):211-7. 
103. Vliet Vlieland TP, van den Ende CH, Breedveld FC, Hazes JM. Evaluation of joint 
mobility in rheumatoid arthritis trials: the value of the EPM-range of motion scale. The 
Journal of rheumatology. 1993;20(12):2010-4. Epub 1993/12/01. 
104. Alexanderson H, Lundberg IE, Stenstrom CH. Development of the myositis activities 
profile--validity and reliability of a self-administered questionnaire to assess activity 
limitations in patients with polymyositis/dermatomyositis. The Journal of rheumatology. 
2002;29(11):2386-92. Epub 2002/11/05. 
105. Gummesson C, Atroshi I, Ekdahl C. The disabilities of the arm, shoulder and hand 
(DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated 
health change after surgery. BMC musculoskeletal disorders. 2003;4:11. Epub 
2003/06/18. 
106. Silva Drummond A, Ferreira Sampaio R, Cotta Mancini M, Noce Kirkwood R, Stamm 
TA. Linking the Disabilities of Arm, Shoulder, and Hand to the International Classification 
of Functioning, Disability, and Health. Journal of hand therapy : official journal of the 
American Society of Hand Therapists. 2007;20(4):336-43; quiz 44. Epub 2007/10/24. 
 72 
107. Tuomi K, Oja G. Work Ability Index. 2nd rev. ed. Helsinki: Institute of Occupational 
Health.; 1998. 
108. Ilmarinen J. The Work Ability Index (WAI). Occupational medicine. 2007(57):160. 
109. Costa AF, Puga-Leal R, Nunes IL. An exploratory study of the Work Ability Index 
(WAI) and its components in a group of computer workers. Work. 2011;39(4):357-67. 
Epub 2011/08/04. 
110. Authority" SWE. Ergonomics for the Prevention of Musculoskeletal Disorders. AFS 
1998:1. Sweden: Swedish Work Environment Authority (Arbetsmiljö verket); 1998. p. 53. 
111. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, 
classification, and diagnostic criteria. Rheumatic diseases clinics of North America. 
2002;28(4):723-41. Epub 2003/01/04. 
112. Ekblad E, Haglund L. WEIS-S version 3. Linköping: Institutionen för samhälle- och 
välfärdsstudier Linköpings universitet.; 2010. 
113. Ekbladh E, Fan CW, Sandqvist J, Hemmingsson H, Taylor R. Work environment 
impact scale: Testing the psychometric properties of the Swedish version. Work. 2013. 
114. Kielhofner G. A model of human occupation : theory and application. 4. ed. 
Baltimore: Williams & Wilkins; 2008. xii, 388 s. p. 
115. Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) 
instruments based on the international classification of functioning, disability and health 
(ICF). Quality of life research : an international journal of quality of life aspects of 
treatment, care and rehabilitation. 2005;14(5):1225-37. Epub 2005/07/29. 
116. Cieza A, Brockow T, Ewert T, Amman E, Kollerits B, Chatterji S, et al. Linking health-
status measurements to the international classification of functioning, disability and 
health. Journal of rehabilitation medicine : official journal of the UEMS European Board of 
Physical and Rehabilitation Medicine. 2002;34(5):205-10. Epub 2002/10/24. 
117. Weiss RE. Modeling longitudinal data. New York ; London: Springer; 2005. xxii, 429 
p. p. 
118. Munro B. Statistical methods for health care research. 4th ed. Philadelphia: J. B: 
Lippincott; 1997. 
119. World Medical A. World medical association declaration of helsinki: Ethical principles 
for medical research involving human subjects. JAMA : the journal of the American 
Medical Association. 2013;310(20):2191-4. 
  73 
120. Regardt M, Welin Henriksson E, Alexanderson H, Lundberg IE. Patients with 
polymyositis or dermatomyositis have reduced grip force and health-related quality of life 
in comparison with reference values: an observational study. Rheumatology. 
2011;50(3):578-85. Epub 2010/11/26. 
121. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 
2003;362(9388):971-82. Epub 2003/09/27. 
122. Regardt M, Schult ML, Axelsson Y, Aldehag A, Alexanderson H, Lundberg IE, et al. 
Hand Exercise Intervention in Patients with Polymyositis and Dermatomyositis: A Pilot 
Study. Musculoskeletal care. 2014. Epub 2014/03/14. 
123. Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, et al. 
Distribution and severity of weakness among patients with polymyositis, dermatomyositis 
and juvenile dermatomyositis. Rheumatology (Oxford). 2009;48(2):134-9. 
124. MacDermid JC, Fehr LB, Lindsay KC. The Effect of Physical Factors on Grip 
Strength and Dexterity. The British Journal of Hand Therapy. 2002(7). 
125. Shipham I, Pitout SJ. Rheumatoid arthritis: hand function, activities of daily living, 
grip strength and essential assistive devices. Curationis. 2003;26(3):98-106. Epub 
2004/03/19. 
126. Saito E, Koike T, Hashimoto H, Miyasaka N, Ikeda Y, Hara M, et al. Efficacy of high-
dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant 
polymyositis and dermatomyositis. Modern rheumatology / the Japan Rheumatism 
Association. 2008;18(1):34-44. Epub 2008/01/25. 
127. Herenius MM, Hoving JL, Sluiter JK, Raterman HG, Lems WF, Dijkmans BA, et al. 
Improvement of work ability, quality of life, and fatigue in patients with rheumatoid arthritis 
treated with adalimumab. Journal of occupational and environmental medicine / American 
College of Occupational and Environmental Medicine. 2010;52(6):618-21. Epub 
2010/06/05. 
128. Hoving JL, Bartelds GM, Sluiter JK, Sadiraj K, Groot I, Lems WF, et al. Perceived 
work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month 
course of TNF inhibitors: prospective intervention study and partial economic evaluation. 
Scandinavian journal of rheumatology. 2009;38(4):246-50. Epub 2009/04/02. 
129. Sandqvist G, Scheja A, Hesselstrand R. Pain, fatigue and hand function closely 
correlated to work ability and employment status in systemic sclerosis. Rheumatology 
(Oxford). 2010;49(9):1739-46. Epub 2010/06/01. 
130. Hagberg M, Forcier L, Kuorinka I. Work related musculoskeletal disorders (WMSDs) 
: a reference book for prevention. London: Taylor & Francis; 1995. 421 s. p. 
 74 
131. Ekbladh E, Thorell LH, Haglund L. Perceptions of the work environment among 
people with experience of long term sick leave. Work. 2010;35(2):125-36. Epub 
2010/02/19. 
132. Wilkie R, Pransky G. Improving work participation for adults with musculoskeletal 
conditions. Best practice & research Clinical rheumatology. 2012;26(5):733-42. Epub 
2012/12/12. 
133. Laas K, Roine R, Rasanen P, Sintonen H, Leirisalo-Repo M. Health-related quality of 
life in patients with common rheumatic diseases referred to a university clinic. 
Rheumatology international. 2009;29(3):267-73. Epub 2008/08/07. 
134. Arvidsson S, Arvidsson B, Fridlund B, Bergman S. Factors promoting health-related 
quality of life in people with rheumatic diseases: a 12 month longitudinal study. BMC 
musculoskeletal disorders. 2011;12:102. Epub 2011/05/24. 
135. Voet NB, van der Kooi EL, Riphagen, II, Lindeman E, van Engelen BG, Geurts A. 
Strength training and aerobic exercise training for muscle disease. Cochrane Database 
Syst Rev. 2010(1):CD003907. Epub 2010/01/22. 
136. Serfass RC, Gerberich SG. Exercise for optimal health: strategies and motivational 
considerations. Preventive medicine. 1984;13(1):79-99. Epub 1984/01/01. 
137. Moseley GL. Do training diaries affect and reflect adherence to home programs? 
Arthritis and rheumatism. 2006;55(4):662-4. Epub 2006/07/29. 
138. Medina-Mirapeix F, Escolar-Reina P, Gascon-Canovas JJ, Montilla-Herrador J, 
Jimeno-Serrano FJ, Collins SM. Predictive factors of adherence to frequency and 
duration components in home exercise programs for neck and low back pain: an 
observational study. BMC musculoskeletal disorders. 2009;10:155. Epub 2009/12/10. 
139. Sandqvist G, Eklund M, Akesson A, Nordenskiold U. Daily activities and hand 
function in women with scleroderma. Scand J Rheumatol. 2004;33(2):102-7. Epub 
2004/05/28. 
140. Nordenskiold U. Daily activities in women with rheumatoid arthritis. Aspects of 
patient education, assistive devices and methods for disability and impairment 
assessment. Scandinavian journal of rehabilitation medicine Supplement. 1997;37:1-72. 
Epub 1997/01/01. 
141. Dziedzic K, Hammond A. Rheumatology : evidence-based practice for 
physiotherapists and occupational therapists. Hammond A, editor. Edinburgh ; New York: 
Churchill Livingstone; 2010a. xv, 362 p. p. 
  75 
142. Sandqvist G, Hesselstrand R, Eberhardt K. A longitudinal follow-up of hand 
involvement and activities of daily living in early systemic sclerosis. Scandinavian journal 
of rheumatology. 2009;38(4):304-10. Epub 2009/03/20. 
143. Bjork M, Thyberg I, Haglund L, Skogh T. Hand function in women and men with early 
rheumatoid arthritis. A prospective study over three years (the Swedish TIRA project). 
Scandinavian journal of rheumatology. 2006;35(1):15-9. Epub 2006/02/10. 
144. Bjork MA, Thyberg IS, Skogh T, Gerdle BU. Hand function and activity limitation 
according to health assessment questionnaire in patients with rheumatoid arthritis and 
healthy referents: 5-year followup of predictors of activity limitation (The Swedish TIRA 
Project). The Journal of rheumatology. 2007;34(2):296-302. Epub 2007/02/15. 
145. Alexanderson H, Dastmalchi M, Esbjornsson-Liljedahl M, Opava CH, Lundberg IE. 
Benefits of intensive resistance training in patients with chronic polymyositis or 
dermatomyositis. Arthritis and rheumatism. 2007;57(5):768-77. Epub 2007/05/29. 
146. Alemo Munters L, van Vollenhoven RF, Alexanderson H. Patient preference 
assessment reveals disease aspects not covered by recommended outcomes in 
polymyositis and dermatomyositis. ISRN rheumatology. 2011;2011:463124. Epub 
2011/01/01. 
147. Bethge M, Radoschewski FM, Gutenbrunner C. The Work Ability Index as a 
screening tool to identify the need for rehabilitation: longitudinal findings from the Second 
German Sociomedical Panel of Employees. Journal of rehabilitation medicine : official 
journal of the UEMS European Board of Physical and Rehabilitation Medicine. 
2012;44(11):980-7. Epub 2012/10/03. 
148. Sandqvist JL, Tornquist KB, Henriksson CM. Assessment of Work Performance 
(AWP)--development of an instrument. Work. 2006;26(4):379-87. PubMed PMID: 
16788257. 
149. Timmerman T, Verrall T, Clatney L, Klomp H, Teare G. Taking a closer look: using 
statistical process control to identify patterns of improvement in a quality-improvement 
collaborative. Quality & safety in health care. 2010 Dec;19(6):e19. PubMed PMID: 
20595718. 
